<SEC-DOCUMENT>0001683168-22-007504.txt : 20221110
<SEC-HEADER>0001683168-22-007504.hdr.sgml : 20221110
<ACCEPTANCE-DATETIME>20221110135312
ACCESSION NUMBER:		0001683168-22-007504
CONFORMED SUBMISSION TYPE:	8-K/A
PUBLIC DOCUMENT COUNT:		14
CONFORMED PERIOD OF REPORT:	20221109
ITEM INFORMATION:		Results of Operations and Financial Condition
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20221110
DATE AS OF CHANGE:		20221110

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			RadNet, Inc.
		CENTRAL INDEX KEY:			0000790526
		STANDARD INDUSTRIAL CLASSIFICATION:	SERVICES-MEDICAL LABORATORIES [8071]
		IRS NUMBER:				133326724
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		8-K/A
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-33307
		FILM NUMBER:		221376317

	BUSINESS ADDRESS:	
		STREET 1:		1510 COTNER AVE
		CITY:			LOS ANGELES
		STATE:			CA
		ZIP:			90025
		BUSINESS PHONE:		3104787808

	MAIL ADDRESS:	
		STREET 1:		1510 COTNER AVE
		CITY:			LOS ANGELES
		STATE:			CA
		ZIP:			90025

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	PRIMEDEX HEALTH SYSTEMS INC
		DATE OF NAME CHANGE:	19930518

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	CCC FRANCHISING CORP
		DATE OF NAME CHANGE:	19920703
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K/A
<SEQUENCE>1
<FILENAME>radnet_8k.htm
<DESCRIPTION>FORM 8-K/A
<TEXT>
<XBRL>
<?xml version="1.0" encoding="utf-8"?>
<html xmlns="http://www.w3.org/1999/xhtml" xmlns:xs="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2015-02-26" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:dei="http://xbrl.sec.gov/dei/2022" xmlns:ref="http://www.xbrl.org/2006/ref" xmlns:us-gaap="http://fasb.org/us-gaap/2022" xmlns:us-gaap-supplement="http://fasb.org/us-gaap-sup/2022q3" xmlns:srt-supplement="http://fasb.org/srt-sup/2022q3" xmlns:us-roles="http://fasb.org/us-roles/2022" xmlns:country="http://xbrl.sec.gov/country/2022" xmlns:srt="http://fasb.org/srt/2022" xmlns:RDNT="http://radnet.com/20221109">
<head>
     <title></title>
<meta http-equiv="Content-Type" content="text/html" />
</head>
<!-- Field: Set; Name: xdx; ID: xdx_02B_US%2DGAAP%2D2022 -->
<!-- Field: Set; Name: xdx; ID: xdx_039_RDNT_radnet.com_20221109 -->
<!-- Field: Set; Name: xdx; ID: xdx_044_20221109_20221109 -->
<!-- Field: Set; Name: xdx; ID: xdx_05C_edei%2D%2DEntityCentralIndexKey_0000790526 -->
<!-- Field: Set; Name: xdx; ID: xdx_05E_edei%2D%2DAmendmentDescription_Adding Transcript -->
<!-- Field: Set; Name: xdx; ID: xdx_055_edei%2D%2DAmendmentFlag_true -->
<!-- Field: Set; Name: xdx; ID: xdx_06B_USD_1_iso4217%2D%2DUSD -->
<!-- Field: Set; Name: xdx; ID: xdx_062_Shares_2_xbrli%2D%2Dshares -->
<!-- Field: Set; Name: xdx; ID: xdx_06D_USDPShares_3_iso4217%2D%2DUSD_xbrli%2D%2Dshares -->
<body style="font: 10pt Times New Roman, Times, Serif">
<div style="display: none">
<ix:header>
 <ix:hidden>
  <ix:nonNumeric contextRef="From2022-11-09to2022-11-09" name="dei:EntityCentralIndexKey">0000790526</ix:nonNumeric>
  <ix:nonNumeric contextRef="From2022-11-09to2022-11-09" name="dei:AmendmentDescription">Adding Transcript</ix:nonNumeric>
  <ix:nonNumeric contextRef="From2022-11-09to2022-11-09" name="dei:AmendmentFlag">true</ix:nonNumeric>
  </ix:hidden>
 <ix:references>
  <link:schemaRef xlink:href="rdnt-20221109.xsd" xlink:type="simple" />
  </ix:references>
 <ix:resources>
    <xbrli:context id="From2022-11-09to2022-11-09">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-11-09</xbrli:startDate>
        <xbrli:endDate>2022-11-09</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:unit id="USD">
      <xbrli:measure>iso4217:USD</xbrli:measure>
    </xbrli:unit>
    <xbrli:unit id="Shares">
      <xbrli:measure>xbrli:shares</xbrli:measure>
    </xbrli:unit>
    <xbrli:unit id="USDPShares">
      <xbrli:divide>
        <xbrli:unitNumerator>
          <xbrli:measure>iso4217:USD</xbrli:measure>
        </xbrli:unitNumerator>
        <xbrli:unitDenominator>
          <xbrli:measure>xbrli:shares</xbrli:measure>
        </xbrli:unitDenominator>
      </xbrli:divide>
    </xbrli:unit>
  </ix:resources>
 </ix:header>
</div>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif">UNITED
STATES</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif"><b>SECURITIES
AND EXCHANGE COMMISSION</b></span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Washington,
D.C. 20549</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"></p>

<!-- Field: Rule-Page --><div style="margin: 3pt auto; width: 25%"><div style="border-top: Black 1pt solid; font-size: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></div></div><!-- Field: /Rule-Page -->

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 14pt"><b>FORM
<span id="xdx_901_edei--DocumentType_c20221109__20221109_znShjq8HiOZk"><ix:nonNumeric contextRef="From2022-11-09to2022-11-09" name="dei:DocumentType">8-K/A</ix:nonNumeric></span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"></p>

<!-- Field: Rule-Page --><div style="margin: 3pt auto; width: 25%"><div style="border-top: Black 1pt solid; font-size: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></div></div><!-- Field: /Rule-Page -->

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif"><b>CURRENT
REPORT</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif"><b>Pursuant
to Section 13 OR 15(d) of The Securities Exchange Act of 1934</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Date
of Report (Date of earliest event reported): <span id="xdx_906_edei--DocumentPeriodEndDate_c20221109__20221109_zMfmwPdu4pT"><ix:nonNumeric contextRef="From2022-11-09to2022-11-09" format="ixt:datemonthdayyearen" name="dei:DocumentPeriodEndDate">November
9, 2022</ix:nonNumeric></span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif">_______________________________________________</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 18pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span id="xdx_90E_edei--EntityRegistrantName_c20221109__20221109_zXWibPtHID1a" style="font-family: Times New Roman, Times, Serif"><b><ix:nonNumeric contextRef="From2022-11-09to2022-11-09" name="dei:EntityRegistrantName">RadNet,
Inc.</ix:nonNumeric></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif">(Exact
name of registrant as specified in its charter)</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<table cellpadding="0" cellspacing="0" border="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt">
<tr style="vertical-align: top">
    <td style="border-bottom: Black 1pt solid; text-align: center; padding-left: 10pt; width: 32%"><b><span id="xdx_900_edei--EntityIncorporationStateCountryCode_c20221109__20221109_zBHv5MSYQ95g" style="font-family: Times New Roman, Times, Serif"><ix:nonNumeric contextRef="From2022-11-09to2022-11-09" format="ixt-sec:stateprovnameen" name="dei:EntityIncorporationStateCountryCode">Delaware</ix:nonNumeric></span></b></td>
    <td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: center; padding-left: 10pt; width: 32%"><span id="xdx_900_edei--EntityFileNumber_c20221109__20221109_zhK8BHTEc9ak" style="font-family: Times New Roman, Times, Serif"><b><ix:nonNumeric contextRef="From2022-11-09to2022-11-09" name="dei:EntityFileNumber">001-33307</ix:nonNumeric></b></span></td>
    <td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: center; width: 32%"><span id="xdx_900_edei--EntityTaxIdentificationNumber_c20221109__20221109_zxjhJQRSngSd" style="font-family: Times New Roman, Times, Serif"><b><ix:nonNumeric contextRef="From2022-11-09to2022-11-09" name="dei:EntityTaxIdentificationNumber">13-3326724</ix:nonNumeric></b></span></td></tr>
<tr style="vertical-align: top">
    <td style="text-align: center; padding-left: 10pt"><span style="font-family: Times New Roman, Times, Serif">(State or other jurisdiction<br />
    of incorporation)</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: center; padding-left: 10pt"><span style="font-family: Times New Roman, Times, Serif">(Commission File Number)</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif">(IRS Employer Identification No.)</span></td></tr>
</table>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 60.9pt; text-indent: -16.75pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><b><span id="xdx_901_edei--EntityAddressAddressLine1_c20221109__20221109_z5YS9A5BCgJ7"><ix:nonNumeric contextRef="From2022-11-09to2022-11-09" name="dei:EntityAddressAddressLine1">1510 Cotner Avenue</ix:nonNumeric></span></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><b><span id="xdx_903_edei--EntityAddressCityOrTown_c20221109__20221109_z89sPk8c2stc"><ix:nonNumeric contextRef="From2022-11-09to2022-11-09" name="dei:EntityAddressCityOrTown">Los Angeles</ix:nonNumeric></span>, <span id="xdx_90B_edei--EntityAddressStateOrProvince_c20221109__20221109_z5CyvAio40K3"><ix:nonNumeric contextRef="From2022-11-09to2022-11-09" format="ixt-sec:stateprovnameen" name="dei:EntityAddressStateOrProvince">California</ix:nonNumeric></span>
<span id="xdx_90B_edei--EntityAddressPostalZipCode_c20221109__20221109_zfAKBqEBQgQ3"><ix:nonNumeric contextRef="From2022-11-09to2022-11-09" name="dei:EntityAddressPostalZipCode">90025</ix:nonNumeric></span></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">(Address of Principal Executive
Offices) (Zip Code)</p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><b>(<span id="xdx_90C_edei--CityAreaCode_c20221109__20221109_zVOuE401uy9k"><ix:nonNumeric contextRef="From2022-11-09to2022-11-09" name="dei:CityAreaCode">310</ix:nonNumeric></span>) <span id="xdx_90F_edei--LocalPhoneNumber_c20221109__20221109_zD01VnhSb0I1"><ix:nonNumeric contextRef="From2022-11-09to2022-11-09" name="dei:LocalPhoneNumber">478-7808</ix:nonNumeric></span></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">(Registrant&#8217;s Telephone
Number, Including Area Code)</p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>N/A</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">(Former name or former address, if changed since
last report.)</p>
<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif">&#160;&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif">_______________________________________________</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: left; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif">Check
the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under
any of the following provisions:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 5.7pt"></td><td style="width: 21.5pt"><span id="xdx_907_edei--WrittenCommunications_c20221109__20221109_zrfGuKXwKfw2" style="font-family: Times New Roman, Times, Serif"><ix:nonNumeric contextRef="From2022-11-09to2022-11-09" format="ixt:booleanfalse" name="dei:WrittenCommunications">&#9744;</ix:nonNumeric></span></td><td><span style="font-family: Times New Roman, Times, Serif">Written
                                            communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 5.7pt"></td><td style="width: 21.5pt"><span id="xdx_900_edei--SolicitingMaterial_c20221109__20221109_z9PDyqLm06t3" style="font-family: Times New Roman, Times, Serif"><ix:nonNumeric contextRef="From2022-11-09to2022-11-09" format="ixt:booleanfalse" name="dei:SolicitingMaterial">&#9744;</ix:nonNumeric></span></td><td><span style="font-family: Times New Roman, Times, Serif">Soliciting
                                            material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 5.7pt"></td><td style="width: 21.5pt"><span id="xdx_902_edei--PreCommencementTenderOffer_c20221109__20221109_zpzXeqAU8prb" style="font-family: Times New Roman, Times, Serif"><ix:nonNumeric contextRef="From2022-11-09to2022-11-09" format="ixt:booleanfalse" name="dei:PreCommencementTenderOffer">&#9744;</ix:nonNumeric></span></td><td><span style="font-family: Times New Roman, Times, Serif">Pre-commencement
                                            communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 5.7pt"></td><td style="width: 21.5pt"><span id="xdx_90C_edei--PreCommencementIssuerTenderOffer_c20221109__20221109_zNi7A8r9dh2g" style="font-family: Times New Roman, Times, Serif"><ix:nonNumeric contextRef="From2022-11-09to2022-11-09" format="ixt:booleanfalse" name="dei:PreCommencementIssuerTenderOffer">&#9744;</ix:nonNumeric></span></td><td><span style="font-family: Times New Roman, Times, Serif">Pre-commencement
                                            communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Securities
registered pursuant to Section 12(b) of the Act:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr>
    <td style="border-bottom: Black 1pt solid; vertical-align: bottom; font-size: 10pt; text-align: center; width: 33%"><p style="margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Title
                                            of each class</b></span></p></td>
    <td style="border-bottom: Black 1pt solid; vertical-align: bottom; font-size: 10pt; text-align: center; width: 34%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Trading
    Symbol(s)</b></span></td>
    <td style="border-bottom: Black 1pt solid; vertical-align: bottom; font-size: 10pt; text-align: center; width: 33%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Name
    of each exchange on which registered</b></span></td></tr>
<tr>
    <td style="vertical-align: bottom; font-size: 10pt; text-align: center"><span id="xdx_901_edei--Security12bTitle_c20221109__20221109_zUqrRPdc5fn4" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonNumeric contextRef="From2022-11-09to2022-11-09" name="dei:Security12bTitle">Common
    Stock, $0.0001 par value</ix:nonNumeric></span></td>
    <td style="vertical-align: top; font-size: 10pt; text-align: center"><span id="xdx_901_edei--TradingSymbol_c20221109__20221109_z7gQJU5FwU42" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonNumeric contextRef="From2022-11-09to2022-11-09" name="dei:TradingSymbol">RDNT</ix:nonNumeric></span></td>
    <td style="vertical-align: bottom; font-size: 10pt; text-align: center"><span id="xdx_902_edei--SecurityExchangeName_c20221109__20221109_zfeKqOt6VRId" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonNumeric contextRef="From2022-11-09to2022-11-09" format="ixt-sec:exchnameen" name="dei:SecurityExchangeName">NASDAQ
    Global Market</ix:nonNumeric></span></td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif">Indicate
by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (&#167;230.405
of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (&#167;240.12b-2 of this chapter).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><span style="font-family: Times New Roman, Times, Serif">Emerging
growth company <span id="xdx_90D_edei--EntityEmergingGrowthCompany_c20221109__20221109_zppfvvMynNu3"><ix:nonNumeric contextRef="From2022-11-09to2022-11-09" format="ixt:booleanfalse" name="dei:EntityEmergingGrowthCompany">&#9744;</ix:nonNumeric></span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif">If an emerging
growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any
new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. &#9744;</span></p>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif"></span></p>

<!-- Field: Page; Sequence: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo; Options: Hidden -->&#160;<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<table cellpadding="0" cellspacing="0" border="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 1in"><b>Item 2.02.</b></td><td><b>RESULTS OF OPERATIONS AND FINANCIAL CONDITION</b></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in">On November
9, 2022 RadNet, Inc. (&#8220;RadNet&#8221;) filed a Current Report on Form 8-K containing a November 9, 2022 press release reporting the
quarter ended September 30, 2022 financial results. Also on November 9, 2022, RadNet held a conference call regarding such financial results.
A copy of the transcript of that conference call is furnished herewith as Exhibit 99.1 to this Current Report.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in">The information
in this Current Report, including Exhibit 99.1 is being furnished and shall not be deemed &#8220;filed&#8221; for purposes of Section
18 of the Securities Exchange Act of 1934 or otherwise subject to the liabilities of that Section. The information in this Current Report,
including Exhibit 99.1 shall not be incorporated by reference into any registration statement or other document filed with the Commission.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellpadding="0" cellspacing="0" border="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt">
<tr style="vertical-align: top">
  <td style="width: 1in"><b>Item 9.01.</b></td>
  <td><b>FINANCIAL STATEMENTS AND EXHIBITS</b></td></tr>
</table>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 34pt">(d)<span style="font-size: 10pt"><b>&#160;&#160;&#160;
</b></span>Exhibits</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; background-color: white; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="width: 18%"><span style="text-decoration: underline"><b>Exhibit Number</b></span></td>
    <td style="width: 82%"><span style="text-decoration: underline"><b>Description of Exhibit</b></span></td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: top">
    <td>99.1</td>
    <td><a href="radnet_ex9901.htm">Transcript of November 9, 2022 conference call.</a></td></tr>
  <tr style="vertical-align: top">
    <td>104</td>
    <td>Cover Page Interactive Data File (embedded within the inline XBRL document)</td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 34pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 34pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 34pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 34pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 34pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 34pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 34pt"></p>

<!-- Field: Page; Sequence: 2 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 34pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>SIGNATURES</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Pursuant to the requirements of the Securities
Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td colspan="2"><b>RADNET, INC.</b></td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td colspan="2">&#160;</td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td colspan="2">&#160;</td></tr>
  <tr style="vertical-align: top">
    <td style="width: 50%">Date: November 10, 2022</td>
    <td style="width: 5%">By:</td>
    <td style="border-bottom: Black 1pt solid; width: 45%">/s/ Mark D. Stolper</td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td>Name:</td>
    <td>Mark D. Stolper</td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td>Title:</td>
    <td>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Chief Financial Officer</p></td></tr>
  </table>
<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif"></span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<p style="margin: 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-weight: normal">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-weight: normal">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-weight: normal">&#160;</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"></span></p>

<!-- Field: Page; Sequence: 3 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;&#160;</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"></span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 21.15pt 0pt 27.2pt; text-align: center">EXHIBIT INDEX</p>
<p style="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left"></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b></b></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; background-color: white; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="width: 18%"><span style="text-decoration: underline"><b>Exhibit Number</b></span></td>
    <td style="width: 82%"><span style="text-decoration: underline"><b>Description</b></span></td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: top">
    <td>99.1</td>
    <td><a href="radnet_ex9901.htm">Transcript of November 9, 2022 conference call.</a></td></tr>
  <tr style="vertical-align: top">
    <td>104</td>
    <td>Cover Page Interactive Data File (embedded within the inline XBRL document)</td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<!-- Field: Page; Sequence: 4; Options: Last -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>


</body>
</html>
<!-- Field: Set; Name: xdx; ID: xdx_08B_extensions -->
<!-- eJxFjd0KwjAMhZ9g7xB6LdpNBbdLh4o4ZYwh3hYXpbg1I61/j+Rb2m2IIRCSc74cIUZiQ2tdI8NpWWRQYtPWyiEUeEFGc0bvSLe7BPws8KqtY2Vcv/7AlDyDnpmPY+XvvfOhLVYJyMVExpMoBDlL5BTyvQg6PSVz0RUap1UNylSQM7Ws0Sl+Dx9K9SJDzbtPOiJbTSaBcCwH+QORDCM40EM9iW8WsiwVwaivQGyY7m0Xc7eOGljV2PgsO6D/Dr7iWkkg -->

</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>2
<FILENAME>radnet_ex9901.htm
<DESCRIPTION>TRANSCRIPT OF NOVEMBER 9, 2022 CONFERENCE CALL
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><B>Exhibit 99.1</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><IMG SRC="image_002.jpg" ALT="" STYLE="height: 446px; width: 625px"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->1<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>C O R P O R A T E &nbsp;&nbsp;&nbsp;P A R T I C I P A N T S</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Mark Stolper, </B><I>Executive Vice President
and Chief Financial Officer</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Howard Berger, MD, </B><I>President and Chief
Executive Officer</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>C O N F E R E N C E &nbsp;&nbsp;C A L L &nbsp;&nbsp;P A R T I C I P
A N T S</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Brian Tanquilut, </B><I>Jefferies</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Mitra Ramgopal, </B><I>Sidoti &amp; Company</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>P R E S E N T A T I O N</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Operator</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Good day, and welcome to the RadNet Inc. Third
Quarter 2022 Financial Results Conference Call.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Today's call is being recorded.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">At this time, I'd like to turn the call over to
Mr. Mark Stolper, Executive Vice President and Chief Financial Officer of RadNet, Inc. Please go ahead.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Mark Stolper</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Thank you. Good morning, ladies and gentlemen,
and thank you for joining Dr. Howard Berger and me today to discuss RadNet's third quarter 2022 financial results.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Before we begin today, we'd like to remind everyone
of the Safe Harbor statement under the Private Securities Litigation Reform Act of 1995. This presentation contains forward-looking statements
within the meaning of the U.S. Private Securities Litigation Reform Act of 1995. Specifically, statements concerning anticipated future
financial and operating performance, RadNet's ability to continue to grow the business by generating patient referrals and contracts with
radiology practices, recruiting and retaining technologists, receiving third-party reimbursement for diagnostic imaging services, successfully
integrating acquired operations, generating revenue and Adjusted EBITDA for the acquired operations as estimated, among others, are forward-looking
statements within the meaning of the Safe Harbor.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 2 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Forward-looking statements are based on Management's
current preliminary expectations and are subject to risks and uncertainties which may cause RadNet's actual results to differ materially
from the statements contained herein. These risks and uncertainties include those risks set forth in RadNet's reports filed with the SEC
from time to time, include RadNet's Annual Report on Form 10-K for the year ended December 31, 2021. Undue reliance should not be placed
on forward-looking statements, especially guidance on future financial performance which speaks only as of the date it is made. RadNet
undertakes no obligation to update publicly any forward-looking statements to reflect new information, events, or circumstances after
the date they were made, or to reflect the occurrence of unanticipated events.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">With that, I'd like to turn the call over to Dr.
Berger.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Howard Berger</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Thank you, Mark. Good morning, everyone, and thank
you for joining us today.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">On today's call, Mark and I plan to provide you
with highlights from our third quarter 2022 results, give you more insight into factors which affected this performance, and discuss our
future strategy. After our prepared remarks, we will open the call to your questions. I'd like to thank all of you for your interest in
our Company and for dedicating a portion of your day to participate in our conference call.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">I would like to say, on behalf of myself and the
entire team at RadNet, we hope all of you and your loved ones are healthy and staying safe.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">During the third quarter, revenue from imaging
centers reporting unit increased 5.2%, aggregate procedural volume increased 5.7, and same store, same center procedural volumes increased
3.9%. This performance would have been substantially better, but for staffing shortages that prevented us from both utilizing the capacity
we have in our facilities and expanding hours to service the growing demand we are experiencing. We believe the strong demand for imaging
services is being driven by increasing efforts from payors to direct procedural volumes outside hospitals into ambulatory freestanding
imaging centers.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">During the quarter, we were forced to utilize
expensive temporary labor and absorb extraordinary amounts of overtime charges, which impacted our EBITDA, profitability, and operating
margins. Although we anticipated increased salaries, benefits, and wages in our initial guidance, the labor market has been more challenging
than we originally projected.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">More recently, we are seeing signs of improvement
in the labor market. In the last couple of months, we have been more effective at filling open positions. In September, our number of
open positions peaked at 850, representing almost 10% of the entire workforce. The latest support I have received in November is that
our open positions have fallen to 262 positions. Additionally, the COVID-19 impact on our work force, which previously hurt our ability
to staff our centers appropriately, has substantially abated.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Furthermore, we believe staffing shortages will
continue to improve as we are noting that many large companies, including the likes of Amazon, Walmart, Twitter, Meta, just to name a
few, and certain large hospital systems have recently announced staffing reductions.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The demand for our services is strong and growing,
we are experiencing increasing patient volumes in virtually all of our regional markets. October was the strongest revenue month we have
experienced all year, and the start to November appears to be equally robust. As a result, we are anticipating improved fourth quarter
performance, which we believe will continue as we move into 2023.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We are focused on executing key company wide initiatives.
I'm going to briefly review some of these initiatives before I turn the call back over to Mark.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">First, as we have discussed throughout the year,
we have been in development of 15 de novo facilities spanning almost all of our markets. Three of these facilities are now open and another
eight facilities should be producing revenue by the end of the second quarter of next year. While de novo facilities have not been a big
part of our historical growth strategy, many of the facilities we are developing are in markets where we have backlogs, capacity constraints,
or where our current network coverage lacks access for certain patient populations.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 3 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Another one of our significant initiatives is
expansion through Hospital and Health System joint ventures. In the past, we have stated that we see a path forward towards holding as
much as 50% of our imaging centers in these partnerships. With two recent JV expansions, which I will discuss shortly, we now have 119
of our facilities, within health system partnerships, are roughly 33% of our entire network of centers.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Most hospitals have been challenged by the loss
of patient volumes to outpatient freestanding facilities who offer significantly lower pricing along with better and more convenient patient
experience. Many of these health systems recognize that creating a partnership with an outpatient operator like RadNet, gives them an
opportunity to participate in recapturing revenue that they have otherwise already lost or will likely lose in the future.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Recently, we announced that our joint venture
with RWJBarnabas Health New Jersey Imaging Network acquired the outpatient radiology assets of Montclair Radiology. For more than 75 years,
Montclair radiology has been a leading provider of diagnostic imaging in northern New Jersey. Montclair Radiology owns and operates six
multimodality centers and performs over 200,000 procedures per year. We are projecting that this acquisition will add over $40 million
of revenue on an annual basis to NJ IN and bring the total number of centers in this joint venture to 30 facilities.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In addition, we completed an expansion of our
Arizona diagnostic radiology joint venture with Dignity Health. In conjunction with the expansion, Dignity Health contributed three hospital-affiliated
outpatient imaging centers into the existing outpatient partnership with RadNet. These locations include one multimodality center and
two women's imaging facilities. In addition to these newly contributed locations by year end 2022, the joint venture will open a 30,000
square foot facility called Park Central in proximity to downtown Phoenix. With this expansion, we now have a platform of 11 centers in
the Phoenix area and look forward to executing on future opportunities to expand our capacity and footprint.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">I am particularly pleased to announce that we
have initiated a pilot of our new enhanced breast cancer detection, EBCD service, in Delaware. The offering works in concert with a patient's
annual breast screening regimen. For an additional fee, patients can elect to enroll in a suite of premium mammography related services,
including the use of detailed Saige-Dx AI, personalized lifetime risk assessment, and additional AI-driven review for certain exams and
access to a dedicated 1-800 support line.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Saige-Dx analyzes each mammogram in detail and
if suspicious findings are present, the AI identifies the lesion in the exam for the radiologist and categorizes the level of suspicion.
Many of our radiologists who have been using Saige-Dx AI indicate that AI has improved their accuracy in detecting breast cancers. Accord
(phon), the name we have given to an additional AI driven review for suspicious findings, is designed to be an effective quality assurance
tool unparalleled in our industry.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">I believe that the innovative EBCD program is
one of the most important endeavors the Company has pursued for our patients. Currently, we perform over 1.4 million screening mammograms
annually, and we anticipate expanding this program to all RadNet markets during the first half of next year. I invite you to read more
about EBCD at www.myebcdmammo.com.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We recently announced the acquisition of a controlling
interest in Heart &amp; Lung Health, a London-based teleradiology network focused on lung cancer screening. With a network of over 70
expert cardiothoracic radiologists, HLH has established itself as the leading provider of lung cancer screening services in the U.K. through
the U.K. national health services targeted Lung Health Check program, which mandates the combined use of AI and expert radiologist interpretation
for widespread population health lung cancer screening.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Under this program, patients aged 55 to 74 who
have ever smoked are being screened through low dose CT for lung cancer and related diseases. In September 2022, the success of this program
pilot originally launched in England paved the way for the UK National Screening Committee to recommend that population-based targeted
screening of lung cancer be introduced for high-risk patients across all of the nations of the UK</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 4 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">HLH utilizes software for RadNet&rsquo;s AI subsidiary
Aidence, and it is anticipated that the program could drive over 1 million lung scans in England alone on an annual basis when the program
becomes fully implemented, which is targeted by the end of 2026. This is Radnet&rsquo;s first example of combining specialty teleradiology
interpretation services with artificial intelligence algorithms to enable a comprehensive cancer screening program.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We believe these types of screening programs combining
specialty radiology interpretation with AI represent the future of widespread population health screening for a variety of cancers and
other chronic diseases.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Lastly, with respect to our growth initiatives,
we believe the opportunities for continuing consolidation could accelerate as a result of reimbursement pressures, challenged labor markets,
and rising interest rates. Low financial leverage, less expensive cost of capital, and greater liquidity places us in a favorable position
to complete accretive acquisitions which may arise.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Our cash balance at the end of the third quarter
was over $95 million, and we are undrawn upon our $195 million revolving credit facility. Our DSOs are at a record low of 37 days, and
we are producing a substantial amount of free cash flow.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In most instances, our scale and operating expertise
provide us unique synergy and cost saving opportunities resulting from local market consolidation. While we are committed to growing and
expanding our business through all of the growth initiatives I have reviewed this morning, we will also continue to follow a methodical
and disciplined approach to managing our financial leverage.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">At this time, I'd like to turn the call back over
to Mark to discuss some of the highlights of our third quarter 2022 performance. When he is finished, I will make some closing remarks.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Mark Stolper</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Thank you, Howard.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">I'm now going to briefly review our third quarter
2022 performance and attempt to highlight what I believe to be some material items. I will also give some further explanation of certain
items in our financial statements, as well as provide some insights into some of the metrics that drove our third quarter performance.
I will also provide an update to 2022 financial guidance levels, which were released in conjunction with our 2021 year end results in
March, and which we amended in May and August upon releasing our first and second quarter financial results.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In my discussion, I will use the term Adjusted
EBITDA, which is a non-GAAP financial measure. The Company defines Adjusted EBITDA as earnings before interest, taxes, depreciation, and
amortization, and excludes losses or gains on the disposal of equipment, either income or loss, loss on debt extinguishment, and noncash
equity compensation. Adjusted EBITDA includes equity earnings in unconsolidated operations and subtracts allocations of earnings to non-controlling
interest in subsidiaries and is adjusted for noncash or extraordinary and one-time events taking place during the period. A full quantitative
reconciliation of Adjusted EBITDA to net income or loss attributable to RadNet Inc, common shareholders is included in our earnings release.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">With that said, I'd now like to review our third
quarter 2022 results.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">For the third quarter of 2022, RadNet reported
revenue from its imaging center&rsquo;s reporting segment of $349.1 million and Adjusted EBITDA of $50.2 million. As compared with last
year's third quarter, revenue increased $17 million, or 5.1%, and Adjusted EBITDA decreased $4.7 million, or 8.5%. This comparison excludes
a one-time benefit for the forgiveness of deferred federal payroll taxes in the third quarter of 2021.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Including our AI reporting segment, revenue was
$350 million in the third quarter of 2022, an increase of 5.2%, from $332.7 million in last year's third quarter. Including the losses
of the AI reporting segment, Adjusted EBITDA was $45.8 million in the third quarter of 2022 and $54.6 million in the third quarter of
2021.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In the third quarter of 2022, RadNet reported
net income of $668,000 as compared with $16.2 million for the third quarter of 2021. Diluted net income per share for the third quarter
of 2022 was $0.01 per share, compared with diluted net income per share $0.30 in the third quarter of 2021, based upon a weighted average
number of diluted shares outstanding of 57.8 million shares in 2022 and 53.8 million shares in 2021.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 5 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">There were a number of unusual, or one-time, items
impacting the third quarter including the following: $11.2 million dollars of noncash gained from interest rate swaps, net of amortization
of the accumulation of the changes in fair value out of other comprehensive income; $8.1 million change in estimate related to refund
liability; $195,000 of severance paid in connection with headcount reductions related to cost savings initiatives; $959,000 expense related
to leases of our de novo facilities under construction that have yet to open their operations; and $7.8 million of pre-tax losses related
to our AI reporting segment.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Adjusting for these items, adjusted earnings from
the imaging centers reporting segment was $5.3 million and diluted adjusted earnings per share was $0.09 during the third quarter of 2022.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Also affecting net income in the third quarter
of 2022 were certain noncash expenses and unusual items including the following: $3.3 million of noncash employee stock compensation expense,
resulting from the vesting of certain options and restricted stock; $247,000 gain on the disposal of certain capital equipment; $959,000
of non-operational rent expense associated with unopened de novo locations; and $648,000 of noncash amortization deferred financing costs
and loan discounts related to financing fees paid as part of our existing credit facilities.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">For the third quarter of 2022, as compared with
the prior year&rsquo;s third quarter, MRI volume increased 10.8%, CT volume increased 9.6%, and PET CT volume increased 11.5%. Overall
volume, taking into account routine imaging exams inclusive of X-ray, ultrasound, mammography and all other exams, increased 5.7% over
the prior year&rsquo;s third quarter.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">On a same center basis, including only those centers
which were part of RadNet for both the third quarters of 2022 and 2021, MRI volume increased 9.2%, CT volume increased 6%, and PET CT
volume increased 9.5%. Overall, same center volume, taking into account all routine imaging exams, increased 3.9% over the prior year
same quarter.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In the third quarter of 2022, we performed 2,311,448
total procedures. The procedures were consistent with our multi-modality approach whereby 75.4% of all the work we did by volume was from
routine imaging. Our procedures in the third quarter of 2022 were as follows: 348,912 MRIs as compared with 314,870 MRIs in the third
quarter of 2021; 207,554 CTs as compared with 189,444 CTs in third quarter of 2021; 12,932 PET CTs as compared with 11,600 PET CTs in
the third quarter of 2021; and 1,742,050 routine imaging exams as compared with 1,670,042 of all these exams in the third quarter of 2021.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Overall GAAP interest expense for the third quarter
of 2022 was $12.4 million. This compares with GAAP interest expense in the third quarter of 2021 of $12 million. Cash paid for interest
during the quarter which excludes noncash deferred financing expense, accrued interest, and payments to swap counterparties was $10.6
million.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">With regards to our balance sheet, as of September
30, 2022, unadjusted for bond and term loan discounts, we had $662.9 million of net debt, which is our total debt at par value less our
cash balance. Note that this debt balance includes New Jersey Imaging Network debt of $42 million for which RadNet is neither a borrower
nor guarantor. As of September 30, 2022, we were undrawn on our $195 million revolving line of credit and had a cash balance of $95 million.
At September 30 2022, our accounts receivable balance was $172.5 million, an increase of $37.4 million from Year End 2021.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Our days sales outstanding, or DSL, was 37 days
at September 30, 2022. The lowest level in our company's history. Through September 30, 2022, we had total capital expenditures, net of
asset dispositions, of $92 million. This excludes $3.6 million of capital expenditures at our New Jersey imaging network joint venture.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">At this time, I'd like to update and revise our
2022 financial guidance levels, which we released in conjunction with our fourth quarter and Year End 2021 results and amended after reporting
our first and second quarter 2022 financial results.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">For revenue from imaging centers, our guidance
is unchanged at $1.360 billion to $1.410 billion. For Adjusted EBITDA, we revised our guidance range $203 million to $208 million. For
capital expenditures, we increased our guidance ranges to $100 million to $105 million. For cash interest expense, we increased our range
to $35 million to $40 million. For free cash flow generation, we decreased our guidance range to $60 million to $70 million.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 6 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We're adjusting our guidance levels to reflect
the challenges that an extremely difficult labor market had on our third quarter results, which Dr. Berger highlighted in his prepared
remarks, and to reflect the anticipated performance for the remainder of 2022.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We are executing on a multitude of growth and
cost savings initiatives that makes us very optimistic and excited about how we are positioned for the upcoming fourth quarter of &rsquo;22
and the full year of 2023.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">I'll now take a few minutes to give you an update
on 2023 reimbursement and discuss what we know with regard to 2023 anticipated Medicare rates.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">As a reminder, Medicare represents 22.3% of our
business mix. With respect to Medicare reimbursement, in July, we received a matrix of proposed rates by CPT code which is typically part
of the Physician Fee Schedule proposal that is released about that time every year. We completed an initial analysis at the time and compared
those rates to 2022 rates. We volume weighted our analysis using expected 2023 procedure volumes.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">As you may recall, two years ago, CMS moved forward
with increased reimbursement for evaluation and management CPT codes, which favor certain physician specialties that regularly bill for
these services, particularly primary care doctors. CMS proposed doing so with budget neutrality, meaning that it proposed to reallocate
reimbursement from physicians who rarely bill for E&amp;M codes to physicians who regularly bill for these codes. As a result, radiology
and most other specialties experienced cuts in reimbursement during 2021 and 2022, cuts meant to be phased in over a several year period.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The cuts we faced in 2022 were substantially mitigated
by a 3% increase to the conversion factor from legislation that was passed at the end of last year as part of the Protecting Medicare
and American Farmers from Sequester Cuts Act.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In this year's proposed rule governing 2023 reimbursement,
Medicare appeared to effectively propose phasing in the remainder of the E&amp;M code related cut avoided last year. The cut proposed
for 2023 results from a decrease in the conversion factor in the Medicare fee schedule by about 4.4%, along with certain minor changes
to the RVUs, or relative value in units, of certain radiology CPT codes. The majority share of this proposed cut came from the expiration
of the one-year 3% increase to the conversion factor during 2022, provided by the Congressional legislation last year.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Our initial analysis of the proposed rule in July
was that&mdash;on RadNet&rsquo;s roughly $1.4 billion in revenue, that we would face in approximately $8 million to $10 million revenue
hit in 2023 from our Medicare business.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">A few weeks ago, CMS released its final rule,
which was essentially in line with its proposal from July, where they proposed a 4.5% decrease to the Medicare conversion factor. Because
the decrease in the conversion factor affects all physicians, not just radiologists, there are many lobbying groups from various medical
specialties aggressively opposing the cut, including radiology&rsquo;s two main lobbying forces the Association for Quality Imaging, or
AQI, and the American College of Radiology, ACR.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Furthermore, many believe that the Protecting
Medicare and American Farmers from Sequester Cuts Act increase will be extended from 2022 through 2023, mitigating the majority of the
conversion factor decline as currently scheduled. We would expect for this to happen towards the end of this year like it did last year.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In fact, in September, U.S. representatives Ami
Bera, Democrat from California, and Larry Bucshon, a Republican from Indiana, introduced bipartisan legislation similar to the bill introduced
by them last year, which was successful in substantially mitigating a similar proposed cut to the 2022 Medicare conversion factor.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The supporting Medicare Providers Act of 2022,
Bera and Bucshon&rsquo;s new bill, would ensure payments to Medicare providers are kept stable and extend certain increases in payments
for physician services under the Medicare program through 2023.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">At this time, our policy experts and lobbyists
believe there is a very high probability that the cuts scheduled to go into effect next year will be fully or partially mitigated by congressional
action with this bill in December.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">I&rsquo;d now like to turn the call back to Dr.
Berger, who will make some closing remarks.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 7 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Howard Berger</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Thank you, Mark.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Despite some of the challenges in the overall
operating and economic environment that we discussed earlier on today's call, I am very enthusiastic about the coming quarters and next
year for RadNet. As the largest, most sophisticated, and best capitalized operator in our industry, we are well positioned, regardless
of what the greater economic or industry specific conditions are like. RadNet is indispensable to the healthcare delivery system and our
regional markets.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Our scale and breadth of capabilities, as well
as our relationships with referring physicians, patients, health systems, and capitated partners create a significant advantage over our
other competitors. These advantages position us to capitalize on opportunities that could arise. Specifically, in difficult times weaker
imaging operators become eager and attractive acquisition candidates and long-term value creating consolidation can be aggressively pursued.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In the coming quarters, we will continue to execute
on the multitude of initiatives that I discussed in my earlier remarks. These include opening the de novo centers we have in development,
expanding our hospital and health system joint venture businesses, rolling out our enhanced breast cancer detection offering to all RadNet
markets, accelerating the commercialization of our AI portfolio, and opportunistically pursuing accretive acquisitions in our core imaging
center business. These initiatives should drive our growth and efficiency and position us for a very strong 2023.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In conclusion, we are excited and enthusiastic
about the opportunities that lie ahead for RadNet, and we look forward to updating you further in the coming quarters regarding our progress.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Operator, we are now ready for the question-and-answer
portion of the call.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Operator</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Thank you.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We'll take our first question from Brian Tanquilut
with Jefferies.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Brian Tanquilut</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Hi. Good morning, guys. Mark, I'll start with
you. As I think about the Q3 results, the revenue line was actually pretty decent, despite some of the challenges of the quarter. But
as I think about the cost lines, how lasting, or how sticky are these challenges on the cost side? I know inflation is obviously an issue
and it sounds like you're getting gaining some traction on the recruitment front. But just curious to your thoughts and the lasting effects
of these headwinds.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Mark Stolper</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Sure. Yes, clearly, we were impacted by labor
challenges, which is similar to what we're seeing in almost every industry, particularly in healthcare. It impacted, Brian, there both
on our revenue side as well as the cost side because we had staffing issues where we had to pay substantially&mdash;our overtime was substantially
higher than normal, we used temporary service. In other cases, we couldn't staff rooms, and so we had to cancel appointments, reschedule
appointments if we could, and so we lost both revenue and our costs were higher during the quarter.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We have seen some recent improvement that gives
us significant amount of confidence moving into the fourth quarter and into the next year on the staffing side. As we said in our prepared
remarks, our open positions peaked in September at about 850 open positions. As of yesterday, the report that came out of HR is that our
open positions are down to about 262 employees. We're doing a lot better on the talent acquisition front.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 8 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">I think, one, we've refined some of the systems,
we've added more recruiters. I think, in general, the market has gotten a little bit more favorable for companies looking to hire. We
have noted that there were some hospitals and health systems in our markets that started doing layoffs. Kaiser made some layoffs here
in California, Adventist Health also announced some layoffs.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">I think we are capitalizing on a labor market
that is certainly stabilized, and what we're seeing is improving going into the fourth quarter. We also have seen that impact not only
our costs as we move into the fourth quarter, but our revenue. We had the strongest revenue in October&mdash;the strongest month all year
in October, and we're seeing very similar per day revenue as we've moved early on here in November, which gives us tremendous confidence
that November is also going to be a strong month.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We have a lot of reason to be optimistic, and
not to mention all of the initiatives that Dr. Berger went through on in his prepared remarks about what should drive incremental revenue
and profitability as we move into 2023.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Howard Berger</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">(Multiple speakers). Hi, Brian. Yes, let me just
amplify on that a little bit. I think that the increased labor costs, once we fully staff up, are here to stay, and we're building that
in anticipation of our 2023 performance. But there are other things that we can do and have been doing here throughout 2022 to help reduce
the dependency that we have on our technological capabilities.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">There are investments that we're making in equipment
that will improve throughput into our centers that will help drive revenue without any further increasing our costs, as well as other
initiatives we're taking in contracting with some payors, as well as expansion that we think will add substantially to our performance,
not only in 2023, but also here in 2022's fourth quarter.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We're anticipating, I think, is where you were
going, Brian, that higher labor costs are going to be here to stay not just for RadNet and healthcare, but throughout other industries,
and the Company is making the appropriate adjustments to ultimately maintain and hopefully grow our margins.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Brian Tanquilut</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Howard or Mark, I'll follow up on that&mdash;you
alluded to heading into 2023. Maybe qualitatively, any moving pieces that we should be thinking about as we think about &rsquo;23. Then
just maybe some views on your ability to drive positive EBITDA growth next year.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Howard Berger</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Yes, Brian, I think there are initiatives, I think
I outlined many of them, but we are working on expanding almost every one of the hospital partner relationships that we have to either
add more facilities or improve the actual performance.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">I think that we will drive revenue substantially
with the 15 new centers that we're developing, the majority of which will be operational by the&mdash;at the end of the first half of
this year. Our average center generates about $4 million or so of revenue. So, 15 new centers ultimately will drive the&mdash;we hope
about $60 million of new revenue, some of which we've already started experiencing, but only recently in the latter part of the second
quarter and into the third quarter so far this year.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">I think we should pay particular attention to
the new initiatives, that I outlined also, that come in the form of artificial intelligence. We're very excited about our enhanced breast
cancer detection program, which we think will have an enormous impact on improving the detection of cancer earlier and better outcomes
for our patients and will be the standard by which screening mammography in breast cancer will be performed. I think that that will contribute
significantly the next year. As I mentioned, we do 1.4 million screening mammograms a year and that number will be growing.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In addition, some of the benefits that we'll get
by the increasing labor positions that we're filling in are&mdash;well, not labor positions but the staffing positions that we're filling,
should decrease our cost of overtime, as well as reducing and hopefully substantially eliminate the temporary staffing agency. I think
we're looking at a significant opportunity to improve our margins next year that will come both from revenue as well as better control
of costs. But higher wages are here to stay, that's for sure.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 9 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Brian Tanquilut</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Mark, shifting gears, or for Howard, EBCD. It
sounds like a really interesting program. Anything you can share with us in terms of greater detail on how it works and what you see the
opportunity there being?</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Howard Berger</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Sure, Brian. The pilot program that we rolled
out last week in Delaware is meeting with very enthusiastic reception by our patients. We are using a lot of collateral, both in terms
of our website and handouts that we give patients, to educate them as to what the value of the service will be. We're charging $59 for
this, which we believe is a very attractive price point. So far, in our centers, we're having between 30% and 40% of the patients enrolled
for this new service.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We expect those numbers to increase significantly,
and we're further buoyed by a report that came out of the United Kingdom, the British Journal of Radiology, which indicated in the survey
they did of women, 88% of them were attracted and encouraged by the use of artificial intelligence for breast imaging.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We believe this is a substantial opportunity,
not only for RadNet, but really the industry as a whole, to get a better handle on managing breast cancer, which one out of every eight
women will suffer from at some time in their life, and there are these technological tools to be more accurate and earlier in cancer detection.
It could have far reaching implications for RadNet, and its partners in the radiology imaging industry as a whole.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Brian Tanquilut</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Appreciate that. Howard, last question for me,
if I may. There's a lot of discussion about Alzheimer's drugs coming up for approval here. Obviously, imaging will be a key part of that
discussion. Just curious how you're thinking about that opportunity and how you're preparing for that potential tailwind if it gets approved?</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Howard Berger</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Well, we've already been doing a fair number of
these studies as part of our research relationships. We think these are good tools. I think as they get adopted through reimbursement,
I think it can have a substantial impact on our revenue. But it's one of many initiatives that we have for evaluating new procedures that
will help better define treatment pathways.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Another one we're working on is PMSA for prostate
cancer metastasis of which we do more than any other imaging operator in the country, and which has gained an enormous amount of acceptance.
If this is adopted, which we all believe it will, all of these patients will need regular MRs to determine both the extent of the potential
Alzheimer disease initially, as well as the effectiveness of treatment given that there are some side effects of these drugs that need
to be carefully monitored.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">I do believe, particularly with the strategy that
RadNet offers of being in densely populated markets, that could be a future large driver of business for us and we stand ready to do that,
as I said&mdash;I repeat, we've been doing many already as a part of these drug research programs.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Brian Tanquilut</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Awesome. Thank you.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Howard Berger</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Thank you, Brian.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Mark Stolper</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Thanks, Brian.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 10 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Operator</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We'll take our next question from Mitra Ramgopal
with Sidoti &amp; Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Mitra Ramgopal</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Yes. Good morning. Thanks for taking the questions.
Howard, just curious, your thoughts as we head into a likely recession next year. How resilient is the business, especially on the volume
side as its structured today in the markets you're in?</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Howard Berger</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Hi, Mitra. Well, generally speaking, healthcare
has been relatively insulated from recessionary factors. In fact, some people say during a recession people need more health care, because
they don't take care of themselves as well as they might in better times. But besides that, as I&rsquo;ve talked about in my prepared
remarks, there is already what we are seeing is a substantial effort on the part of payors to drive more of the outpatient businesses
away from hospitals, and we expect that to continue.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">I think both because of aging population, increasing
population, and screening tools that are uniquely done in outpatient facilities, more so than in hospitals, and better pricing, all point
to a rather optimistic approach for our volumes in 2023. I think that a lot of these efforts to move the business away from hospitals
have finally taken root here as payors become more aggressive about doing this.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">As you've seen, almost all the payors as well
as other new entrants into healthcare, delivery of primary health care, like Walgreens and CVS, even Walmart, will be involved in bringing
healthcare more to where people live and where they may shop and spend more time, and we expect to be a part of that program. We'll probably
have more information on that in our next close call for the fourth quarter.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">I don't think volume for us, Mitra, is a concern.
I think handling that volume and improving our margins and keeping our costs controlled after the experience that we had in 2022, and
from which we have learned an awful lot about how to even better manage the operations, will be of substantial benefit for us in 2023.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Mitra Ramgopal</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Okay. Thanks for that. On the expansion in Arizona,
if I remember, it was off to a slower start than you might have anticipated, but it would appear based on the expansion that you're pretty
comfortable with that market and the growth opportunities there now?</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Howard Berger</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Definitely. We hope to have some more announcements
about further efforts to expand our reach in not only the Phoenix area, but in other relationships that we have with the Dignity Health
System inside of Arizona and in other markets also. We certainly have benefited already from establishing a strong relationship with the
Dignity Health System, which while it took longer than we wanted, will be one of our major joint venture partners here for the future.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Mitra Ramgopal</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Okay. Thanks. If you can help us in terms of as
you look at the growth opportunities, how you prioritize them, whether it's a JV, M&amp;A, de novo, investments in AI. Any sense in terms
of the importance of those opportunities for you?</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Howard Berger</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Well, I think they're all very good opportunities
for us. Perhaps where I might want you to focus on or at least keep your eye on is that the recent announcement that we made into acquiring
a majority position for the U.K.-based Heart &amp; Lung Health program could be a template for future expansion on the teleradiology side.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 11 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->11<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">One of the ways that radiology in particular is
going to need to change is further recognition of the fact that the labor shortage that we talked about is not only with the non-professional
side of our industry, but also on the professional side of it. There are too few radiologists in fellowship programs that are coming out
into the marketplace than jobs currently being offered, and the increasing demand for these services are going to necessitate changes
in the way that the delivery of the professional component is delivered.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">I think for RadNet in particular, this represents
a great opportunity for us to not only with the current state that we've made in teleradiology but get deeper into specialty teleradiology
reading networks, which will enhance our opportunity to combine this with artificial intelligence and create superior outcomes. But also,
in general, address some of the shortages that we and everybody else is experiencing by taking our large base of radiologists and creating
our own teleradiology initiatives here.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">I don't know if I could put any of the things
that I've mentioned in my prepared remarks as a greater priority. They're all priorities, and they're all incredibly exciting opportunities
for us to pursue.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">RadNet is in the process of not being just the
outpatient imaging center, but really leading radiology even further into the future by using technology to drive opportunities, both
on the revenue side and on the controlling on the expense side. I'm sure we're going to have more to talk about this as we get deeper
into 2023.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Mitra Ramgopal</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Okay. Thanks. Finally, just following up on that
a little, looking, I think&mdash;looking ahead, I think you mentioned, the higher costs are here to stay on the labor front. We're just
wondering if that might give you some pause as you look to expand your de novo strategy and even adding more imaging centers at this point?</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Howard Berger</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">I don't think it'll slow us down from doing that
because the demand is there, and as I mentioned in our de novo remarks&mdash;in my remarks about the de novo centers, a lot of these are
to really increase capacity for demand that we already have. I think part of the experience and challenges that we have with our labor
costs are things that we're talking to the payors and others about the need for better reimbursement. While that's always been an effort
on the part of the Company to improve reimbursement, I think that is even a greater opportunity for us to have these conversations.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">As I mentioned, we're just an incredibly essential
part of healthcare delivery in all of our markets, and it's incumbent upon everybody that needs our services to understand that these
kinds of increased costs has to be borne by the payors as well as others to keep RadNet&mdash;be the contributor it is and the importance
that it is. Everybody has to take that into consideration.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We have very receptive groups out there. Although
these don't culminate in overnight, we're having very good success along those lines in terms of trying to offset and keep our margins
higher by improve reimbursement from all of our payor contracts.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B></B></P>

<!-- Field: Page; Sequence: 12 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->12<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Mitra Ramgopal</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Okay. Thanks again for taking the questions.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Howard Berger</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Thank you, Mitra. Take care.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Mark Stolper</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Thanks, Mitra.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Operator&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">With no additional questions in queue, I'd like
to turn the call back over to our speakers for any additional or closing remarks.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Howard Berger</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Okay. Thank you, Operator.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">I would like again to take this opportunity thank
all of our shareholders for their continued support, and the employers of RadNet&mdash;and employees of RadNet, and the employers for
that matter, for their dedication and hard work. Management will continue its endeavor to be a market leader that provides great services
with an appropriate return on investment for all stakeholders. Thank you for your time today and I look forward to speaking with you on
our next call.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Operator&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">That will conclude today's call. We appreciate
your participation.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 13; Options: Last -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->13<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>3
<FILENAME>rdnt-20221109.xsd
<DESCRIPTION>XBRL SCHEMA FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" ?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 5.16b -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
    <!-- Field: Doc-Info; Name: Misc; Value: +Kopo7xRiXgen8uEbXpMOaeH6aPty552uYkxvmR1fckqPygmEw1tRCvH6OdW4WYG -->
<schema xmlns="http://www.w3.org/2001/XMLSchema" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:dei="http://xbrl.sec.gov/dei/2022" xmlns:us-gaap="http://fasb.org/srt-sup/2022q3" xmlns:srt="http://fasb.org/srt/2022" xmlns:srt-types="http://fasb.org/srt-types/2022" xmlns:RDNT="http://radnet.com/20221109" elementFormDefault="qualified" targetNamespace="http://radnet.com/20221109">
    <annotation>
      <appinfo>
	<link:roleType roleURI="http://radnet.com/role/Cover" id="Cover">
	  <link:definition>00000001 - Document - Cover</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:linkbaseRef xlink:type="simple" xlink:href="rdnt-20221109_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:title="Presentation Links" />
	<link:linkbaseRef xlink:type="simple" xlink:href="rdnt-20221109_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:title="Label Links" />
      </appinfo>
    </annotation>
    <import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd" />
    <import namespace="http://www.xbrl.org/2003/linkbase" schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" />
    <import namespace="http://xbrl.sec.gov/dei/2022" schemaLocation="https://xbrl.sec.gov/dei/2022/dei-2022.xsd" />
    <import namespace="http://fasb.org/us-gaap/2022" schemaLocation="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd" />
    <import namespace="http://fasb.org/us-gaap-sup/2022q3" schemaLocation="https://xbrl.fasb.org/us-gaap/2022q3/us-gaap-sup-2022q3.xsd" />
    <import namespace="http://fasb.org/srt-sup/2022q3" schemaLocation="https://xbrl.fasb.org/srt/2022q3/srt-sup-2022q3.xsd" />
    <import namespace="http://fasb.org/us-types/2022" schemaLocation="https://xbrl.fasb.org/us-gaap/2022/elts/us-types-2022.xsd" />
    <import namespace="http://www.xbrl.org/dtr/type/2020-01-21" schemaLocation="https://www.xbrl.org/dtr/type/2020-01-21/types.xsd" />
    <import namespace="http://xbrl.sec.gov/country/2022" schemaLocation="https://xbrl.sec.gov/country/2022/country-2022.xsd" />
    <import namespace="http://fasb.org/srt/2022" schemaLocation="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd" />
    <import namespace="http://fasb.org/srt-types/2022" schemaLocation="https://xbrl.fasb.org/srt/2022/elts/srt-types-2022.xsd" />
</schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>4
<FILENAME>rdnt-20221109_lab.xml
<DESCRIPTION>XBRL LABEL FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 5.16b -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel" roleURI="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel" roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel" roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel" roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel" roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel" roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel" roleURI="http://www.xbrl.org/2009/role/netLabel" />
    <link:labelLink xlink:type="extended" xlink:role="http://www.xbrl.org/2003/role/link">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CoverAbstract" xlink:label="dei_CoverAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CoverAbstract" xlink:to="dei_CoverAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CoverAbstract_lbl" xml:lang="en-US">Cover [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentType" xlink:label="dei_DocumentType" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentType" xlink:to="dei_DocumentType_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentType_lbl" xml:lang="en-US">Document Type</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AmendmentFlag" xlink:label="dei_AmendmentFlag" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentFlag" xlink:to="dei_AmendmentFlag_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AmendmentFlag_lbl" xml:lang="en-US">Amendment Flag</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AmendmentDescription" xlink:label="dei_AmendmentDescription" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentDescription" xlink:to="dei_AmendmentDescription_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AmendmentDescription_lbl" xml:lang="en-US">Amendment Description</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentRegistrationStatement" xlink:label="dei_DocumentRegistrationStatement" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentRegistrationStatement" xlink:to="dei_DocumentRegistrationStatement_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentRegistrationStatement_lbl" xml:lang="en-US">Document Registration Statement</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentAnnualReport" xlink:label="dei_DocumentAnnualReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentAnnualReport" xlink:to="dei_DocumentAnnualReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentAnnualReport_lbl" xml:lang="en-US">Document Annual Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentQuarterlyReport" xlink:label="dei_DocumentQuarterlyReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentQuarterlyReport" xlink:to="dei_DocumentQuarterlyReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentQuarterlyReport_lbl" xml:lang="en-US">Document Quarterly Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentTransitionReport" xlink:label="dei_DocumentTransitionReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentTransitionReport" xlink:to="dei_DocumentTransitionReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentTransitionReport_lbl" xml:lang="en-US">Document Transition Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentShellCompanyReport" xlink:label="dei_DocumentShellCompanyReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentShellCompanyReport" xlink:to="dei_DocumentShellCompanyReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentShellCompanyReport_lbl" xml:lang="en-US">Document Shell Company Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentShellCompanyEventDate" xlink:label="dei_DocumentShellCompanyEventDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentShellCompanyEventDate" xlink:to="dei_DocumentShellCompanyEventDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentShellCompanyEventDate_lbl" xml:lang="en-US">Document Shell Company Event Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentPeriodStartDate" xlink:label="dei_DocumentPeriodStartDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentPeriodStartDate" xlink:to="dei_DocumentPeriodStartDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentPeriodStartDate_lbl" xml:lang="en-US">Document Period Start Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentPeriodEndDate" xlink:label="dei_DocumentPeriodEndDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentPeriodEndDate" xlink:to="dei_DocumentPeriodEndDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentPeriodEndDate_lbl" xml:lang="en-US">Document Period End Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="dei_DocumentFiscalPeriodFocus" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentFiscalPeriodFocus" xlink:to="dei_DocumentFiscalPeriodFocus_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentFiscalPeriodFocus_lbl" xml:lang="en-US">Document Fiscal Period Focus</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentFiscalYearFocus" xlink:label="dei_DocumentFiscalYearFocus" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentFiscalYearFocus" xlink:to="dei_DocumentFiscalYearFocus_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentFiscalYearFocus_lbl" xml:lang="en-US">Document Fiscal Year Focus</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CurrentFiscalYearEndDate" xlink:label="dei_CurrentFiscalYearEndDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CurrentFiscalYearEndDate" xlink:to="dei_CurrentFiscalYearEndDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CurrentFiscalYearEndDate_lbl" xml:lang="en-US">Current Fiscal Year End Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityFileNumber" xlink:label="dei_EntityFileNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFileNumber" xlink:to="dei_EntityFileNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityFileNumber_lbl" xml:lang="en-US">Entity File Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityRegistrantName" xlink:label="dei_EntityRegistrantName" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityRegistrantName" xlink:to="dei_EntityRegistrantName_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityRegistrantName_lbl" xml:lang="en-US">Entity Registrant Name</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCentralIndexKey" xlink:label="dei_EntityCentralIndexKey" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCentralIndexKey" xlink:to="dei_EntityCentralIndexKey_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCentralIndexKey_lbl" xml:lang="en-US">Entity Central Index Key</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityPrimarySicNumber" xlink:label="dei_EntityPrimarySicNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityPrimarySicNumber" xlink:to="dei_EntityPrimarySicNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityPrimarySicNumber_lbl" xml:lang="en-US">Entity Primary SIC Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityTaxIdentificationNumber" xlink:label="dei_EntityTaxIdentificationNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityTaxIdentificationNumber" xlink:to="dei_EntityTaxIdentificationNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityTaxIdentificationNumber_lbl" xml:lang="en-US">Entity Tax Identification Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="dei_EntityIncorporationStateCountryCode" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityIncorporationStateCountryCode" xlink:to="dei_EntityIncorporationStateCountryCode_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityIncorporationStateCountryCode_lbl" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressAddressLine1" xlink:label="dei_EntityAddressAddressLine1" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine1" xlink:to="dei_EntityAddressAddressLine1_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressAddressLine1_lbl" xml:lang="en-US">Entity Address, Address Line One</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressAddressLine2" xlink:label="dei_EntityAddressAddressLine2" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine2" xlink:to="dei_EntityAddressAddressLine2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressAddressLine2_lbl" xml:lang="en-US">Entity Address, Address Line Two</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressAddressLine3" xlink:label="dei_EntityAddressAddressLine3" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine3" xlink:to="dei_EntityAddressAddressLine3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressAddressLine3_lbl" xml:lang="en-US">Entity Address, Address Line Three</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressCityOrTown" xlink:label="dei_EntityAddressCityOrTown" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressCityOrTown" xlink:to="dei_EntityAddressCityOrTown_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressCityOrTown_lbl" xml:lang="en-US">Entity Address, City or Town</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressStateOrProvince" xlink:label="dei_EntityAddressStateOrProvince" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressStateOrProvince" xlink:to="dei_EntityAddressStateOrProvince_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressStateOrProvince_lbl" xml:lang="en-US">Entity Address, State or Province</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressCountry" xlink:label="dei_EntityAddressCountry" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressCountry" xlink:to="dei_EntityAddressCountry_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressCountry_lbl" xml:lang="en-US">Entity Address, Country</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressPostalZipCode" xlink:label="dei_EntityAddressPostalZipCode" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressPostalZipCode" xlink:to="dei_EntityAddressPostalZipCode_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressPostalZipCode_lbl" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CountryRegion" xlink:label="dei_CountryRegion" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CountryRegion" xlink:to="dei_CountryRegion_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CountryRegion_lbl" xml:lang="en-US">Country Region</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CityAreaCode" xlink:label="dei_CityAreaCode" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CityAreaCode" xlink:to="dei_CityAreaCode_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CityAreaCode_lbl" xml:lang="en-US">City Area Code</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_LocalPhoneNumber" xlink:label="dei_LocalPhoneNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_LocalPhoneNumber" xlink:to="dei_LocalPhoneNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_LocalPhoneNumber_lbl" xml:lang="en-US">Local Phone Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_Extension" xlink:label="dei_Extension" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Extension" xlink:to="dei_Extension_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_Extension_lbl" xml:lang="en-US">Extension</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_WrittenCommunications" xlink:label="dei_WrittenCommunications" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_WrittenCommunications" xlink:to="dei_WrittenCommunications_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_WrittenCommunications_lbl" xml:lang="en-US">Written Communications</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_SolicitingMaterial" xlink:label="dei_SolicitingMaterial" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SolicitingMaterial" xlink:to="dei_SolicitingMaterial_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_SolicitingMaterial_lbl" xml:lang="en-US">Soliciting Material</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_PreCommencementTenderOffer" xlink:label="dei_PreCommencementTenderOffer" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementTenderOffer" xlink:to="dei_PreCommencementTenderOffer_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_PreCommencementTenderOffer_lbl" xml:lang="en-US">Pre-commencement Tender Offer</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="dei_PreCommencementIssuerTenderOffer" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementIssuerTenderOffer" xlink:to="dei_PreCommencementIssuerTenderOffer_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_PreCommencementIssuerTenderOffer_lbl" xml:lang="en-US">Pre-commencement Issuer Tender Offer</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_Security12bTitle" xlink:label="dei_Security12bTitle" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Security12bTitle" xlink:to="dei_Security12bTitle_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_Security12bTitle_lbl" xml:lang="en-US">Title of 12(b) Security</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_NoTradingSymbolFlag" xlink:label="dei_NoTradingSymbolFlag" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_NoTradingSymbolFlag" xlink:to="dei_NoTradingSymbolFlag_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_NoTradingSymbolFlag_lbl" xml:lang="en-US">No Trading Symbol Flag</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_TradingSymbol" xlink:label="dei_TradingSymbol" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_TradingSymbol" xlink:to="dei_TradingSymbol_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_TradingSymbol_lbl" xml:lang="en-US">Trading Symbol</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_SecurityExchangeName" xlink:label="dei_SecurityExchangeName" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SecurityExchangeName" xlink:to="dei_SecurityExchangeName_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_SecurityExchangeName_lbl" xml:lang="en-US">Security Exchange Name</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_Security12gTitle" xlink:label="dei_Security12gTitle" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Security12gTitle" xlink:to="dei_Security12gTitle_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_Security12gTitle_lbl" xml:lang="en-US">Title of 12(g) Security</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_SecurityReportingObligation" xlink:label="dei_SecurityReportingObligation" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SecurityReportingObligation" xlink:to="dei_SecurityReportingObligation_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_SecurityReportingObligation_lbl" xml:lang="en-US">Security Reporting Obligation</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AnnualInformationForm" xlink:label="dei_AnnualInformationForm" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AnnualInformationForm" xlink:to="dei_AnnualInformationForm_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AnnualInformationForm_lbl" xml:lang="en-US">Annual Information Form</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AuditedAnnualFinancialStatements" xlink:label="dei_AuditedAnnualFinancialStatements" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AuditedAnnualFinancialStatements" xlink:to="dei_AuditedAnnualFinancialStatements_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AuditedAnnualFinancialStatements_lbl" xml:lang="en-US">Audited Annual Financial Statements</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityWellKnownSeasonedIssuer" xlink:label="dei_EntityWellKnownSeasonedIssuer" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityWellKnownSeasonedIssuer" xlink:to="dei_EntityWellKnownSeasonedIssuer_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityWellKnownSeasonedIssuer_lbl" xml:lang="en-US">Entity Well-known Seasoned Issuer</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityVoluntaryFilers" xlink:label="dei_EntityVoluntaryFilers" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityVoluntaryFilers" xlink:to="dei_EntityVoluntaryFilers_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityVoluntaryFilers_lbl" xml:lang="en-US">Entity Voluntary Filers</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCurrentReportingStatus" xlink:label="dei_EntityCurrentReportingStatus" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCurrentReportingStatus" xlink:to="dei_EntityCurrentReportingStatus_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCurrentReportingStatus_lbl" xml:lang="en-US">Entity Current Reporting Status</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityInteractiveDataCurrent" xlink:label="dei_EntityInteractiveDataCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityInteractiveDataCurrent" xlink:to="dei_EntityInteractiveDataCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityInteractiveDataCurrent_lbl" xml:lang="en-US">Entity Interactive Data Current</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityFilerCategory" xlink:label="dei_EntityFilerCategory" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFilerCategory" xlink:to="dei_EntityFilerCategory_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityFilerCategory_lbl" xml:lang="en-US">Entity Filer Category</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntitySmallBusiness" xlink:label="dei_EntitySmallBusiness" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntitySmallBusiness" xlink:to="dei_EntitySmallBusiness_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntitySmallBusiness_lbl" xml:lang="en-US">Entity Small Business</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityEmergingGrowthCompany" xlink:label="dei_EntityEmergingGrowthCompany" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityEmergingGrowthCompany" xlink:to="dei_EntityEmergingGrowthCompany_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityEmergingGrowthCompany_lbl" xml:lang="en-US">Entity Emerging Growth Company</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityExTransitionPeriod" xlink:label="dei_EntityExTransitionPeriod" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityExTransitionPeriod" xlink:to="dei_EntityExTransitionPeriod_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityExTransitionPeriod_lbl" xml:lang="en-US">Elected Not To Use the Extended Transition Period</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentAccountingStandard" xlink:label="dei_DocumentAccountingStandard" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentAccountingStandard" xlink:to="dei_DocumentAccountingStandard_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentAccountingStandard_lbl" xml:lang="en-US">Document Accounting Standard</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_OtherReportingStandardItemNumber" xlink:label="dei_OtherReportingStandardItemNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_OtherReportingStandardItemNumber" xlink:to="dei_OtherReportingStandardItemNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_OtherReportingStandardItemNumber_lbl" xml:lang="en-US">Other Reporting Standard Item Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityShellCompany" xlink:label="dei_EntityShellCompany" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityShellCompany" xlink:to="dei_EntityShellCompany_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityShellCompany_lbl" xml:lang="en-US">Entity Shell Company</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityPublicFloat" xlink:label="dei_EntityPublicFloat" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityPublicFloat" xlink:to="dei_EntityPublicFloat_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityPublicFloat_lbl" xml:lang="en-US">Entity Public Float</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityBankruptcyProceedingsReportingCurrent" xlink:label="dei_EntityBankruptcyProceedingsReportingCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityBankruptcyProceedingsReportingCurrent" xlink:to="dei_EntityBankruptcyProceedingsReportingCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityBankruptcyProceedingsReportingCurrent_lbl" xml:lang="en-US">Entity Bankruptcy Proceedings, Reporting Current</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCommonStockSharesOutstanding" xlink:label="dei_EntityCommonStockSharesOutstanding" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCommonStockSharesOutstanding" xlink:to="dei_EntityCommonStockSharesOutstanding_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCommonStockSharesOutstanding_lbl" xml:lang="en-US">Entity Common Stock, Shares Outstanding</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentsIncorporatedByReferenceTextBlock" xlink:label="dei_DocumentsIncorporatedByReferenceTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentsIncorporatedByReferenceTextBlock" xlink:to="dei_DocumentsIncorporatedByReferenceTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentsIncorporatedByReferenceTextBlock_lbl" xml:lang="en-US">Documents Incorporated by Reference [Text Block]</link:label>
    </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>5
<FILENAME>rdnt-20221109_pre.xml
<DESCRIPTION>XBRL PRESENTATION FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 5.16b -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
    <link:roleRef roleURI="http://radnet.com/role/Cover" xlink:href="rdnt-20221109.xsd#Cover" xlink:type="simple" />
    <link:presentationLink xlink:type="extended" xlink:role="http://radnet.com/role/Cover" xlink:title="00000001 - Document - Cover">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CoverAbstract" xlink:label="loc_deiCoverAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentType" xlink:label="loc_deiDocumentType" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentType" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AmendmentFlag" xlink:label="loc_deiAmendmentFlag" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiAmendmentFlag" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AmendmentDescription" xlink:label="loc_deiAmendmentDescription" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiAmendmentDescription" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentRegistrationStatement" xlink:label="loc_deiDocumentRegistrationStatement" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentRegistrationStatement" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentAnnualReport" xlink:label="loc_deiDocumentAnnualReport" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentAnnualReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentQuarterlyReport" xlink:label="loc_deiDocumentQuarterlyReport" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentQuarterlyReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentTransitionReport" xlink:label="loc_deiDocumentTransitionReport" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentTransitionReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentShellCompanyReport" xlink:label="loc_deiDocumentShellCompanyReport" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentShellCompanyReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentShellCompanyEventDate" xlink:label="loc_deiDocumentShellCompanyEventDate" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentShellCompanyEventDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentPeriodStartDate" xlink:label="loc_deiDocumentPeriodStartDate" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentPeriodStartDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentPeriodEndDate" xlink:label="loc_deiDocumentPeriodEndDate" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentPeriodEndDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="loc_deiDocumentFiscalPeriodFocus" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentFiscalPeriodFocus" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentFiscalYearFocus" xlink:label="loc_deiDocumentFiscalYearFocus" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentFiscalYearFocus" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CurrentFiscalYearEndDate" xlink:label="loc_deiCurrentFiscalYearEndDate" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiCurrentFiscalYearEndDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityFileNumber" xlink:label="loc_deiEntityFileNumber" />
      <link:presentationArc order="140" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityFileNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityRegistrantName" xlink:label="loc_deiEntityRegistrantName" />
      <link:presentationArc order="150" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityRegistrantName" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCentralIndexKey" xlink:label="loc_deiEntityCentralIndexKey" />
      <link:presentationArc order="160" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityCentralIndexKey" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityPrimarySicNumber" xlink:label="loc_deiEntityPrimarySicNumber" />
      <link:presentationArc order="170" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityPrimarySicNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityTaxIdentificationNumber" xlink:label="loc_deiEntityTaxIdentificationNumber" />
      <link:presentationArc order="180" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityTaxIdentificationNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="loc_deiEntityIncorporationStateCountryCode" />
      <link:presentationArc order="190" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityIncorporationStateCountryCode" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressAddressLine1" xlink:label="loc_deiEntityAddressAddressLine1" />
      <link:presentationArc order="200" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressAddressLine1" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressAddressLine2" xlink:label="loc_deiEntityAddressAddressLine2" />
      <link:presentationArc order="210" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressAddressLine2" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressAddressLine3" xlink:label="loc_deiEntityAddressAddressLine3" />
      <link:presentationArc order="220" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressAddressLine3" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressCityOrTown" xlink:label="loc_deiEntityAddressCityOrTown" />
      <link:presentationArc order="230" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressCityOrTown" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressStateOrProvince" xlink:label="loc_deiEntityAddressStateOrProvince" />
      <link:presentationArc order="240" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressStateOrProvince" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressCountry" xlink:label="loc_deiEntityAddressCountry" />
      <link:presentationArc order="250" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressCountry" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressPostalZipCode" xlink:label="loc_deiEntityAddressPostalZipCode" />
      <link:presentationArc order="260" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressPostalZipCode" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CountryRegion" xlink:label="loc_deiCountryRegion" />
      <link:presentationArc order="270" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiCountryRegion" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CityAreaCode" xlink:label="loc_deiCityAreaCode" />
      <link:presentationArc order="280" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiCityAreaCode" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_LocalPhoneNumber" xlink:label="loc_deiLocalPhoneNumber" />
      <link:presentationArc order="290" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiLocalPhoneNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_Extension" xlink:label="loc_deiExtension" />
      <link:presentationArc order="300" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiExtension" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_WrittenCommunications" xlink:label="loc_deiWrittenCommunications" />
      <link:presentationArc order="310" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiWrittenCommunications" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_SolicitingMaterial" xlink:label="loc_deiSolicitingMaterial" />
      <link:presentationArc order="320" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSolicitingMaterial" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_PreCommencementTenderOffer" xlink:label="loc_deiPreCommencementTenderOffer" />
      <link:presentationArc order="330" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiPreCommencementTenderOffer" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="loc_deiPreCommencementIssuerTenderOffer" />
      <link:presentationArc order="340" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiPreCommencementIssuerTenderOffer" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_Security12bTitle" xlink:label="loc_deiSecurity12bTitle" />
      <link:presentationArc order="350" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSecurity12bTitle" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_NoTradingSymbolFlag" xlink:label="loc_deiNoTradingSymbolFlag" />
      <link:presentationArc order="360" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiNoTradingSymbolFlag" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_TradingSymbol" xlink:label="loc_deiTradingSymbol" />
      <link:presentationArc order="370" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiTradingSymbol" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_SecurityExchangeName" xlink:label="loc_deiSecurityExchangeName" />
      <link:presentationArc order="380" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSecurityExchangeName" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_Security12gTitle" xlink:label="loc_deiSecurity12gTitle" />
      <link:presentationArc order="390" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSecurity12gTitle" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_SecurityReportingObligation" xlink:label="loc_deiSecurityReportingObligation" />
      <link:presentationArc order="400" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSecurityReportingObligation" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AnnualInformationForm" xlink:label="loc_deiAnnualInformationForm" />
      <link:presentationArc order="410" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiAnnualInformationForm" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AuditedAnnualFinancialStatements" xlink:label="loc_deiAuditedAnnualFinancialStatements" />
      <link:presentationArc order="420" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiAuditedAnnualFinancialStatements" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityWellKnownSeasonedIssuer" xlink:label="loc_deiEntityWellKnownSeasonedIssuer" />
      <link:presentationArc order="430" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityWellKnownSeasonedIssuer" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityVoluntaryFilers" xlink:label="loc_deiEntityVoluntaryFilers" />
      <link:presentationArc order="440" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityVoluntaryFilers" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCurrentReportingStatus" xlink:label="loc_deiEntityCurrentReportingStatus" />
      <link:presentationArc order="450" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityCurrentReportingStatus" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityInteractiveDataCurrent" xlink:label="loc_deiEntityInteractiveDataCurrent" />
      <link:presentationArc order="460" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityInteractiveDataCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityFilerCategory" xlink:label="loc_deiEntityFilerCategory" />
      <link:presentationArc order="470" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityFilerCategory" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntitySmallBusiness" xlink:label="loc_deiEntitySmallBusiness" />
      <link:presentationArc order="480" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntitySmallBusiness" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityEmergingGrowthCompany" xlink:label="loc_deiEntityEmergingGrowthCompany" />
      <link:presentationArc order="490" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityEmergingGrowthCompany" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityExTransitionPeriod" xlink:label="loc_deiEntityExTransitionPeriod" />
      <link:presentationArc order="500" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityExTransitionPeriod" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentAccountingStandard" xlink:label="loc_deiDocumentAccountingStandard" />
      <link:presentationArc order="510" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentAccountingStandard" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_OtherReportingStandardItemNumber" xlink:label="loc_deiOtherReportingStandardItemNumber" />
      <link:presentationArc order="520" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiOtherReportingStandardItemNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityShellCompany" xlink:label="loc_deiEntityShellCompany" />
      <link:presentationArc order="530" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityShellCompany" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityPublicFloat" xlink:label="loc_deiEntityPublicFloat" />
      <link:presentationArc order="540" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityPublicFloat" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityBankruptcyProceedingsReportingCurrent" xlink:label="loc_deiEntityBankruptcyProceedingsReportingCurrent" />
      <link:presentationArc order="550" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityBankruptcyProceedingsReportingCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCommonStockSharesOutstanding" xlink:label="loc_deiEntityCommonStockSharesOutstanding" />
      <link:presentationArc order="560" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityCommonStockSharesOutstanding" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentsIncorporatedByReferenceTextBlock" xlink:label="loc_deiDocumentsIncorporatedByReferenceTextBlock" />
      <link:presentationArc order="570" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentsIncorporatedByReferenceTextBlock" xlink:type="arc" />
    </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>6
<FILENAME>image_002.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 image_002.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0@)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" '[ L8# 2(  A$! Q$!_\0
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MU=;7V-G:XN/DY>;GZ.GJ\O/T]?;W^/GZ_]H # ,!  (1 Q$ /P#TF^=QJ%R
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M_?;\Z/,?^^WYU-11['S%]:\B'S'_ +[?G1YC_P!]OSJ7%%/V/F'UKR(O,?\
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M6B@!*3%.I*8AM%.I,4 )24M% A**** "DI:*8"448HH$)12T4 )1110!9O\
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M***!!24M% Q****!!1110 E%+24P"BBBD E%+24P"DI:*!"44N*2@!*2G4E
M"4E.I*!"4E+13$)28I:* &TE.(I*!"4E.I*8"4E+10(:124ZC%,!E%+BB@0V
MBEI* &D4E/I"*!#**=BDIB&TE.I*!"8IM/I*8#:3%.Q24"&TE/I,4Q#:2G4E
M AM)BG44P&44ZDQ0(;12T4Q#:,4M% AF**=2$4"$I*6B@!*0BEHIB&T4N*2@
M I*6B@0E%%% !1110!/?_P#(1N?^NK_S-;5M_P >L/\ N+_*L6__ .0C<_\
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MBF(;24[%)0 VDIU)0(2DQ3J2F(;24XBDH$)12TE,0E)BG4E #:*7%% AU_\
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M;7$8DC<=P1G\Z^<O"7PONO%O@C5]>F:0W\I)T_<W^M922Y;UW'*@GH036_\
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MNTU>VP!,O[R/.3'(.&4_0_F,'O6Q7SI\(O$UQX2\87'AG5LPP7<WDLCG_4W
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MP<R2_CCCU 4=:^A=>TM]:T.[TU+R6S^TIY;31 %E4_> SZC(_&N:\#?#32_
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M]DFN]6B=[*_;^SW+7]M'M/0X5L<9[\?_ *DL88YW\%QRHKIY=PV&&1D*"/U
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MHI*,T#%HHHH$+1244#%HHHH **** $Q12T4 )1110(*2EHH&)1110(*2EHH
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M_P"P#6M.-YNV_9Q=)YF?3;G.:YW6_%^H:;\3-!\-PPVS6>H0M)*[JQD4C?\
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M7++2;:*WMY-+#K;QC;&&Q&>%& .<_F:Q? FC^%]<^'FOZCXL*?;?M<AO+V0
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M E:YMQR 8]@.T#H,#.1CG@5U.H:#/K?PG\+6DWB/2?M<,Y>U-Y(T<5XH8A5
MD56) *@?+R/KFO1M4^'?A+6M4.I:AHD$MV3N9PS)O/JP4@-^(-:>J^'-'UO2
MTTW4=.@GLTQY<17 CP,#;C!7 XXQ18;F>9^$+JVT?XC6VEZUX2L](U^YMB(K
MC2YL02( 2=T2MM7.P\D9R!TZU!\/;F"W/Q+,TT<>VZE9M[ 8&91D_C7HN@>!
M?#/ABX:XT?28K>=@5\TNTC@'J 7)(_"HKWX=^$M1U>35;S0[>6\ER7<E@&)Z
MDJ#M)]\9HL',CQ^#_DV6Y_Z_1_Z.6M/QII]C)J7PI:6SMV-T8(K@M$I\Y ;<
M!7X^889N#ZGUKU-? OAM?##>'!IO_$I9_,-OY\G+9#9W;MW4#O4NK^#?#^NZ
M5:Z9J6G)<6EHH6!#(ZF,  ## AN@'?FBP<QYWXQ\*S7'CVVO?#Y\.:E-;V20
M?V#?%#LC4<;(\X"X(QTQ6W\)]3TF>/6=-L=#.C7MI< WMLERTT6\[AE"20/N
MD8'' ZUOZE\._">KVUI;WVC12I:1+#"0[JRH.B[E(8@>YK4T/P[I'AJS-IH]
MA%:0L=S!,DL?4DY)_$T[:BYM+'G_ ,:TDMH?#6LM&[V>GZDKW&P9P"5(/_CI
M'U(]:Z34/BCX.T_2EU#^V[:Y5]NV&V</,<GNF<C'4YQTKJ[FV@O;:2VNH8YH
M)5*O'(H96'H0>M<K;?"WP3:7PO(?#]OYP;<-[NZ _P"XS%?THU"ZMJ<=\1[V
MVUKQ)X%CO7=?#=_)YT@ES&LA.W:'!Z<$=?[QHO[*QT'XX^';?PS!#:FYMW%_
M;6@"H4PQ!91P.!G\ :]1U?1-,UZP-CJME%=6Q.?+D'0^H/4'W%4/#_@OP[X6
M:1]%TN*UDD&UI-S.Y'IN8DX]LT6"^AYKX-\/Z3KGQ3\=?VK807BPW&$2=-ZK
MN9\G!XSQP>H[5A>&;>"?X'>+K:>&.=+*\E>W,JAC&VQ!E<]#UY']X^M>WZ;X
M:TC2-5U#4[&T\J\U!@]U)YCMYAR3T)('4] *JVO@CP[8Z+?Z1;Z?LL+]B]S%
MYTA\PG )R6R.@Z$4K#YCQ?Q';+8_!GPG]BM[:VBU">+[=)L\M9B Q7S67!(Z
MG\/:MK1-'U#2_BQHI>?PO87+6S>99:+'< 3P%6^9OD*9XSDD9P/:O5_^$9T8
M^'DT!]/BDTM$"+;R$N !R.22<CUSFJWA_P $^'/"TLLNC:7%:RRC:\FYG<CT
MW,20.!P..*+!S'F?P]\/:7K7Q&\?3:G8V]W]GU%EC2>,.%+32DD ]#\@YZUS
M]O9:GK?BGQQ-<0^&YI()Y!.VNB4O#""X!BV=  !R.?NU[KI/AK2-#O\ 4K[3
MK3R;G4I?.NW\QV\Q\L<X8D#EVZ8ZU0UKX?>%?$.H"_U31H9[KC,H9T+8Z;MI
M&[TYS18.;4\=U^.>+]GO3XY;^*_B340L$\0D"F,;\ >8JMP<CICBMGQOH6E^
M&];^'UUI-C#:3&]C61XEVM*-T9^<]6/)Y//)KU35?"FAZUHL.C7VGH^G0E3'
M;QLT2IM! QL(Z GBG:KX8T?6Y-/DU"S\YM.D$MJ?-=?+88YX(S]T=<]*+!S'
MF\-E9:Y\>];M/$<$-S%!8K]AM[H!H\80DJ#P3RQ_$^G&;X@.C:1\*?$MIX-U
M6]N;5+Y4N@X.V#<P#(C;%RIP!P3P>O//J?B#P7X=\4M&^M:7%=21C"R;F1P/
M3<I!Q[9JW9>'='T_13H]KIUO'IS*5:WV95P>N[/7/O187,>'0Z-?66I^"[I)
M_"6G2R21M9MIB7)FND^4,)"$8'(."6QU/.,U[W?PO<Z=<P1G#R1,BGT)! K#
MT7X?^%?#VHG4-+T>&"[YQ*7=RN>NW<3MXXXQ724TA2=SQ[X0>*M$T3PK/HFK
MZA;Z;J%G=2>;%>2"+.3V+8R1@C'7BNK'Q$T#6-$\13Z>;B[CTNWD:;:K1B08
M/W''K@X/7O6CKGP_\*^([O[7JNCPS7!^]*KO&S=N2A&?QK3TWP_I&D:8^FV&
MG6\%FX(>%4X?(P=V?O9''-%F@;3U/FSQ!I^?ASIVN10:%IUM<7)%M:V<):Y.
M"V2\SDN<8Z9QR.G2O2?$+%OC=X(9B239$DGO\LE=4/A1X'$4\8T"';/C?^]D
MR,'/RG=E>G\./3I6Q)X4T675]/U62S+7VG1>3:S&9R43!&,;L-U/)R:213DC
M@_AS_P E1\?_ /7RO_H;UZI67IOAO2=(U34-2L;3RKS4&WW4GF.WF')/0D@=
M3T K5JD9R=V)1113$)24ZDH ;12XHH$-Q12T4Q#<44M% &-?_P#(1N?^NK_S
M-(OW1]*6_P#^0C<_]=7_ )FD7[H^E31W9>*V0ZC-)2UT'".S13:7- QU+3:6
M@8ZBFTM(!V:6FTH- QV:6FT4ACJ6FYI:!CJ6FTM(!:<#3*6@8^BF@TN:0QU%
M)1F@8ZES3:6@!U+30:6D,6EI** '44E% QV:6FT4@'4M-S2T#%I:;FEH&+2T
MVEI .HI*6@84M)10 M%%% "T4E%(8M%%%,!:*2BD M%%% !2TE% "T49HH&%
M+244"%HI*6@84444 %)2T4 )12TE @I*6B@8E%+24""BBB@!**6BF E%%%(!
M**6BF E%%% A**6DH 2BEHH ;24ZDH$)12XHI@8E_P#\A&Y_ZZO_ #--7[H^
ME.O_ /D(W/\ UU?^9I@Z"E1W8\5\*'T4F:*Z#A'9HI**!CLTM-HI .I:;FEH
M*'4M-I:0"YIV:92T#'4N:;FEI#'4N:92YH&.I:;2T@'4N:;10,>#2TRE!I#'
M4M)FB@!U%)10,?FBFTH- QU%)2T@%I:;6?KVJ_V'X?O]4\GSOLD#S>5NV[]H
MSC.#C\J!K4TJ7-<AX*\>VGC/0KF_BM_L]S;$B:U,N\KQE3NP,@@>G4'TJQX%
M\7?\)IX?.J_8?L>)VA\KS?,Z '.=H]?2E<JS1U%%-S3LT"%HI*6@!:6FTN:0
MQ:6N:\;^*O\ A#?#<FK_ &+[9LD2/RO-\O.XXSG!_E6[9W'VNQM[G;L\Z-9-
MN<XR,XS0.W4L4444 +125SWC#Q?:>$--AN)H);JYN91!:VL/WI7/;/8>_N*!
MHZ*EKC/#OCM]4\0S>'M9T:;1M82+SD@>99EE3U5P "?;V/H:[*EN#5A:*YKQ
MAXQ@\)6MH6LI[Z[O9A!;6T. 7<XZD]!D@=^2*H:!X\FO_$Q\.:YH<VBZLT/G
MPQ-<+,DJ<]&4#G@_D?2BX[/<[2EKS:]^*[13:C=6'ANZO]#TV?R+O44G5=K9
MP=J$98<CN.#GBMGQ#\0++1M,TFYLK2?5)]8*BQ@@^7S-P!!)/W?O#MGGV."Z
M#E9V%%<9X?\ 'KZAK]QH&N:-+HNK10_:%B>=9DDC[D.H )_P/I6*WQ:NI+*Y
MUBS\(WT_A^UE,<U\;A$<8."1$1DCD=^.^*5Q\K/3:*JZ;J%MJVF6VH6;[[:Y
MC66-L8RI&15JF2+124M PHHHH$+124M PHHHH **** $HI:*!"4444#$HI:*
M!"4444 %)2T4 )1113 *2EHI )12TE,04E+10 E)2T4 )12T4 85_P#\A&Y_
MZZO_ #-1CH*DO_\ D(W/_75_YFHQT%%'=AB_A0M*#245T' .I:;FEH&+2TVE
MH 6E!IM+2&.I:93LT#%I:;2TACJ7--I:!CJ*;2YH <#2TVC-(8^BDHH&.I:;
M2T@'9I<TVB@8^BD!I:0Q:6FTM QV:6F9I: '9KGO'O\ R(&O_P#7C+_Z":Z#
M-4]7TR'6='N],N&D6"ZB:)VC(# $8.,@C/X4F4GJ>":/%<>!M&T#QC9H[Z=J
M,#6NIQ+DX)9@&_(#'NN/XJO>'=9OM"^ &HW>G.T5PU^8A*O6,-L!(]#CC/O7
MK<'@_2X?!@\+/YLVG^4T692"^"2<Y  R"<@X["HM$\#:/HGA>X\.J)KO3[AF
M:1;I@Q.X#NH'H,=P:CE9KSI[GFWB;PW9>#/!&F>*]$O;J+60T#R71N&;[5O&
M3N4G!'? [=<ULZW=#PG\2]&\5SKY%CK5I]GON#\D@4$$_DG_ 'R:W;/X5:!;
M7-L\USJE[;6K[[>QN[KS+>$_[*8_F36]XJ\*Z=XPT;^S-2,RQ"195>$@.K#/
M()!'0D=.]%@YD>9^'[C4++X=^+?'J@IJ>JR.\#=3'&&V@CZ$M_WR*YB"QURQ
MT71_$&GZ.=/U"21)3K-WK\0%[D$[6C=@.<=,YP#G->_V^B6%OX?CT,0!]/2W
M%MY3\[DV[<'UR*Y?3OA5X?T^^MI_/U*YM[27SK:QN;K?;POG.57'KZD^^:3B
MQJ:.7U;2;?7OCS]AO_.%M)I@,T44S1[P!G:Q4@XSCH>U8OA;PM8ZO<>.=(O9
M[V33-%FE6RM?M+A$8M( ^ >2!$O7CKQ7KO\ PB5A_P )I_PE7G7/V[[/]G\O
M<OE;?7&W.?QJ+2?!.FZ->:_<V\]VSZY(9+D2.I"$ES\F%&/]8>N>U'*'/H>0
MW=]<WW[.,;74[S/'?"-6=LG:'.!D^F:N^,M&M_!_AGPUXMT6ZNFUEY8$EN&N
M&?[2K1EN021CY0,#C!Q7H7_"LM%_X0G_ (13[5?_ &#SO/\ ,\Q/-W9SUV8Q
M^%1V_P *O#\&HV=T\^I7$-D0UM97%T7@B;U52..1G&<>U%F/G1Q/C&74O$GQ
M9O="DT6;7+&PM%>+3EU 6B$E4)D+'[Q!?&!ST]#2:8^KP_"SQKIVHF/[-:@B
MUC&H17;0*2<Q,R,2-N!U ZGCT]'\1> ]*\1ZG#JCSW]AJ42>6MWI\_E2%?0G
M!'<]L\T^W\!Z+:>$+KPU;+/#9W8/GRJX,KL<98L01G@=L>U%F',K&!\*/">G
M6OAK2/$+I))JTUH4,[3,0(RWRJ%)P   .!ZU-\5-$DU*ST>_M+NSBO\ 3KQ9
MK>&[F6)9SD?("2.<A?UKL=#TBWT#1+32K5Y7@M8Q&C2D%B/<@ ?I5;Q-X8TS
MQ;I)T[5(W:,.)$>-MKQN.C*?7D_G3MH3S>]<\K2;7M1^/GA^YU:PAT^Z%FQ^
MRQ3B8Q1!91\[ 8))+=.Q6O;JYGPYX'TOPU>3W\4U[?:C.@C>]OY_-E*#HN<#
M X';L/2JO@GPL_A[4/$-XR21IJ5[YT<4LBNP SDDJ,#+,Q YP,9YS0M!MIFS
MXD\1Z=X5T6;5-2E*PQ\*J\M(QZ*H[DUYYX T_6/%_C%OB%K<(MH!$8=-M\<A
M#D;OIAFY[EB>!BNQ\9^ M-\<I:1ZG>7\,=J6*):R(H8MCEMRG)&./J:CT/P(
MNAZE;W:>)_$MVD (6UO+_P R%@5*X*;1G&<CT(%)WN":2/-_!3QQ_ #Q4DGR
MR+)<K*&'.\QIC/OTKL?#?B6S\'?!O1M2UB0@+; 11K]Z4DDHJCUQC^=7-1^%
M7A[4=2N;HS:C;P7<@ENK*WN2EO</G.77'KSP15GQ9\.-&\80Z?!>7%[:V]@A
M2""S=$0 X'0J>@4 4K-#;3.8^'>EZSXE\53_ !!UZ(6XFA,6GVP'W8S_ !?3
M&<'ON)X&*J^._%-]XVU63P%X303!VVZA>'[B*I&1GL 1R>_0>_9Z5X"&E7/G
M+XJ\3W(\IXQ%=:@)(QN4C.W;U&<CT(%8NG?!K2M(,ATSQ)XGLO-QYGV:^6/?
MC.,[4&>I_.BS'=7N=UH>E0Z%H=CI5NQ:*TA6)6/5L#J?KUJ_533+'^S=-M[/
M[5<W7DIM\^ZDWRO[LW<U;JC,**** "EI** %HHHH&%+244"%HHHH&%%%% !2
M4M% "4444""DI:*!B4444""BBB@!**6DI@%%%%(!**6DI@%)2T4"$HI:* ,&
M_P#^0C<_]=7_ )FHAT%2W_\ R$;G_KJ_\S4(HH[L,7\*'4M-S2UTGGBT4E+2
M&+FEIM+F@!U%)2T#%HI*6D,4&EIM+F@8ZBDHS0,=2TVEI .S2TVC- QU*#29
MHI#'4M-S2T#'9HI**0#J4&FTM QV:6FYI0:0Q:6DHH&.I<TVEH =2TRG9I#%
MI<TVEH 6EIM+0,6ES244@'44F:6@8M%)2T +2TVEI#'44F:*!BTM)10 M%)2
MT &:6DHH&+1112 *6DHI@+1112 *7-)10 M%)2T#"C-%% A:*2EH&%%%% !1
M110 E%+24""BBB@8E%+24""BBB@ I*6B@!****8!24M%(!****8C!O\ _D(W
M/_75_P"9J'M4U_\ \A&Y_P"NK_S-044=V+%_"A:4&DHKI. =13<T[- "T4E+
MFD,*7-)10 ZEIH-+0,6EI**!BTN:2BD ZEIN:6@8ZBDHI#'4N:;2T#'44F:6
M@!<TM-I<TACJ6FTM Q:6FTM(8X&G9IE+F@!U+30:6D,6EIM+0,<#2TVES0,=
M1244@'44E% QU&:2EH =FBFTN:0QU%)10 ZBDHI#'4M-I: %HI*6@8M%)2T
M%+244 +124M(84M)13 6BDI:0!1110 M%)10 M%%% "T4E% "T444#"BBB@
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-I10,**** "BBB@#_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>7
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm139820945268384">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Cover<br></strong></div></th>
<th class="th"><div>Nov. 09, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CoverAbstract', window );"><strong>Cover [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">8-K/A<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">true<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AmendmentDescription', window );">Amendment Description</a></td>
<td class="text">Adding Transcript<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Nov.  09,  2022<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">001-33307<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">RadNet,
Inc.<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0000790526<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">13-3326724<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation, State or Country Code</a></td>
<td class="text">DE<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">1510 Cotner Avenue<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">Los Angeles<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">CA<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">90025<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">310<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">478-7808<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_WrittenCommunications', window );">Written Communications</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SolicitingMaterial', window );">Soliciting Material</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementTenderOffer', window );">Pre-commencement Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementIssuerTenderOffer', window );">Pre-commencement Issuer Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Common
    Stock, $0.0001 par value<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">RDNT<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NASDAQ<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">false<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentDescription">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Description of changes contained within amended document.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentDescription</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CoverAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Cover page.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CoverAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementIssuerTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 13e<br> -Subsection 4c<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementIssuerTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 14d<br> -Subsection 2b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SolicitingMaterial">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Section 14a<br> -Number 240<br> -Subsection 12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SolicitingMaterial</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_WrittenCommunications">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br> -Section 425<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_WrittenCommunications</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>8
<FILENAME>radnet_8k_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:dei="http://xbrl.sec.gov/dei/2022"
  xmlns:iso4217="http://www.xbrl.org/2003/iso4217"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xlink="http://www.w3.org/1999/xlink">
    <link:schemaRef xlink:href="rdnt-20221109.xsd" xlink:type="simple"/>
    <context id="From2022-11-09to2022-11-09">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
        </entity>
        <period>
            <startDate>2022-11-09</startDate>
            <endDate>2022-11-09</endDate>
        </period>
    </context>
    <unit id="USD">
        <measure>iso4217:USD</measure>
    </unit>
    <unit id="Shares">
        <measure>shares</measure>
    </unit>
    <unit id="USDPShares">
        <divide>
            <unitNumerator>
                <measure>iso4217:USD</measure>
            </unitNumerator>
            <unitDenominator>
                <measure>shares</measure>
            </unitDenominator>
        </divide>
    </unit>
    <dei:EntityCentralIndexKey contextRef="From2022-11-09to2022-11-09">0000790526</dei:EntityCentralIndexKey>
    <dei:AmendmentDescription contextRef="From2022-11-09to2022-11-09">Adding Transcript</dei:AmendmentDescription>
    <dei:AmendmentFlag contextRef="From2022-11-09to2022-11-09">true</dei:AmendmentFlag>
    <dei:DocumentType contextRef="From2022-11-09to2022-11-09">8-K/A</dei:DocumentType>
    <dei:DocumentPeriodEndDate contextRef="From2022-11-09to2022-11-09">2022-11-09</dei:DocumentPeriodEndDate>
    <dei:EntityRegistrantName contextRef="From2022-11-09to2022-11-09">RadNet, Inc.</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode contextRef="From2022-11-09to2022-11-09">DE</dei:EntityIncorporationStateCountryCode>
    <dei:EntityFileNumber contextRef="From2022-11-09to2022-11-09">001-33307</dei:EntityFileNumber>
    <dei:EntityTaxIdentificationNumber contextRef="From2022-11-09to2022-11-09">13-3326724</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1 contextRef="From2022-11-09to2022-11-09">1510 Cotner Avenue</dei:EntityAddressAddressLine1>
    <dei:EntityAddressCityOrTown contextRef="From2022-11-09to2022-11-09">Los Angeles</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince contextRef="From2022-11-09to2022-11-09">CA</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode contextRef="From2022-11-09to2022-11-09">90025</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode contextRef="From2022-11-09to2022-11-09">310</dei:CityAreaCode>
    <dei:LocalPhoneNumber contextRef="From2022-11-09to2022-11-09">478-7808</dei:LocalPhoneNumber>
    <dei:WrittenCommunications contextRef="From2022-11-09to2022-11-09">false</dei:WrittenCommunications>
    <dei:SolicitingMaterial contextRef="From2022-11-09to2022-11-09">false</dei:SolicitingMaterial>
    <dei:PreCommencementTenderOffer contextRef="From2022-11-09to2022-11-09">false</dei:PreCommencementTenderOffer>
    <dei:PreCommencementIssuerTenderOffer contextRef="From2022-11-09to2022-11-09">false</dei:PreCommencementIssuerTenderOffer>
    <dei:Security12bTitle contextRef="From2022-11-09to2022-11-09">Common     Stock, $0.0001 par value</dei:Security12bTitle>
    <dei:TradingSymbol contextRef="From2022-11-09to2022-11-09">RDNT</dei:TradingSymbol>
    <dei:SecurityExchangeName contextRef="From2022-11-09to2022-11-09">NASDAQ</dei:SecurityExchangeName>
    <dei:EntityEmergingGrowthCompany contextRef="From2022-11-09to2022-11-09">false</dei:EntityEmergingGrowthCompany>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>9
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
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M"0U_7/Q$9CS:P'RKK.LU2FY^*OF)P&=F5?1Z1;X/;J#84Y(Q3;8L00M 6!:
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M"H[<8R6,<6*T_C6"R0_L?@!02P,$%     @ I6YJ5:K$(A8S 0  (@(   \
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M4$L! A0#%     @ I6YJ51LA.%GN    *P(  !$              ( !KP
M &1O8U!R;W!S+V-O<F4N>&UL4$L! A0#%     @ I6YJ59E<G",0!@  G"<
M !,              ( !S $  'AL+W1H96UE+W1H96UE,2YX;6Q02P$"% ,4
M    " "E;FI5GU:..&($   1$0  &               @($-"   >&PO=V]R
M:W-H965T<R]S:&5E=#$N>&UL4$L! A0#%     @ I6YJ59^@&_"Q @  X@P
M  T              ( !I0P  'AL+W-T>6QE<RYX;6Q02P$"% ,4    " "E
M;FI5EXJ[',     3 @  "P              @ &!#P  7W)E;',O+G)E;'-0
M2P$"% ,4    " "E;FI5JL0B%C,!   B @  #P              @ %J$
M>&PO=V]R:V)O;VLN>&UL4$L! A0#%     @ I6YJ520>FZ*M    ^ $  !H
M             ( !RA$  'AL+U]R96QS+W=O<FMB;V]K+GAM;"YR96QS4$L!
M A0#%     @ I6YJ5660>9(9 0  SP,  !,              ( !KQ(  %M#
G;VYT96YT7U1Y<&5S72YX;6Q02P4&      D "0 ^ @  ^1,

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>10
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>11
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
..report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

..report table.authRefData a {
	display: block;
	font-weight: bold;
}

..report table.authRefData p {
	margin-top: 0px;
}

..report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

..report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

..report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

..report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
..pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
..report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

..report hr {
	border: 1px solid #acf;
}

/* Top labels */
..report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

..report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

..report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

..report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

..report td.pl div.a {
	width: 200px;
}

..report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
..report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
..report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
..report .re, .report .reu {
	background-color: #def;
}

..report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
..report .ro, .report .rou {
	background-color: white;
}

..report .rou td {
	border-bottom: 1px solid black;
}

..report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
..report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
..report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

..report .nump {
	padding-left: 2em;
}

..report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
..report .text {
	text-align: left;
	white-space: normal;
}

..report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

..report .text .more {
	display: none;
}

..report .text .note {
	font-style: italic;
	font-weight: bold;
}

..report .text .small {
	width: 10em;
}

..report sup {
	font-style: italic;
}

..report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>12
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.22.2.2</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>1</ContextCount>
  <ElementCount>23</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>0</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>3</UnitCount>
  <MyReports>
    <Report instance="radnet_8k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>00000001 - Document - Cover</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://radnet.com/role/Cover</Role>
      <ShortName>Cover</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File doctype="8-K/A" original="radnet_8k.htm">radnet_8k.htm</File>
    <File>radnet_ex9901.htm</File>
    <File>rdnt-20221109.xsd</File>
    <File>rdnt-20221109_lab.xml</File>
    <File>rdnt-20221109_pre.xml</File>
  </InputFiles>
  <SupplementalFiles/>
  <BaseTaxonomies>
    <BaseTaxonomy items="23">http://xbrl.sec.gov/dei/2022</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>false</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>14
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "instance": {
  "radnet_8k.htm": {
   "axisCustom": 0,
   "axisStandard": 0,
   "contextCount": 1,
   "dts": {
    "inline": {
     "local": [
      "radnet_8k.htm"
     ]
    },
    "labelLink": {
     "local": [
      "rdnt-20221109_lab.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "rdnt-20221109_pre.xml"
     ]
    },
    "schema": {
     "local": [
      "rdnt-20221109.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/2006/ref-2006-02-27.xsd",
      "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd",
      "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd",
      "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd",
      "https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd",
      "https://xbrl.fasb.org/srt/2022/elts/srt-roles-2022.xsd",
      "https://xbrl.fasb.org/srt/2022/elts/srt-types-2022.xsd",
      "https://xbrl.fasb.org/srt/2022q3/srt-sup-2022q3.xsd",
      "https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd",
      "https://xbrl.fasb.org/us-gaap/2022/elts/us-roles-2022.xsd",
      "https://xbrl.fasb.org/us-gaap/2022/elts/us-types-2022.xsd",
      "https://xbrl.fasb.org/us-gaap/2022q3/us-gaap-sup-2022q3.xsd",
      "https://xbrl.sec.gov/country/2022/country-2022.xsd",
      "https://xbrl.sec.gov/dei/2022/dei-2022.xsd"
     ]
    }
   },
   "elementCount": 59,
   "entityCount": 1,
   "hidden": {
    "http://xbrl.sec.gov/dei/2022": 3,
    "total": 3
   },
   "keyCustom": 0,
   "keyStandard": 23,
   "memberCustom": 0,
   "memberStandard": 0,
   "nsprefix": "RDNT",
   "nsuri": "http://radnet.com/20221109",
   "report": {
    "R1": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "b",
       "span",
       "p",
       "body",
       "html"
      ],
      "baseRef": "radnet_8k.htm",
      "contextRef": "From2022-11-09to2022-11-09",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "document",
     "isDefault": "true",
     "longName": "00000001 - Document - Cover",
     "role": "http://radnet.com/role/Cover",
     "shortName": "Cover",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "b",
       "span",
       "p",
       "body",
       "html"
      ],
      "baseRef": "radnet_8k.htm",
      "contextRef": "From2022-11-09to2022-11-09",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    }
   },
   "segmentCount": 0,
   "tag": {
    "dei_AmendmentDescription": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Description of changes contained within amended document.",
        "label": "Amendment Description"
       }
      }
     },
     "localname": "AmendmentDescription",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://radnet.com/role/Cover"
     ],
     "xbrltype": "stringItemType"
    },
    "dei_AmendmentFlag": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.",
        "label": "Amendment Flag"
       }
      }
     },
     "localname": "AmendmentFlag",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://radnet.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_AnnualInformationForm": {
     "auth_ref": [
      "r14"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag with value true on a form if it is an annual report containing an annual information form.",
        "label": "Annual Information Form"
       }
      }
     },
     "localname": "AnnualInformationForm",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://radnet.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_AuditedAnnualFinancialStatements": {
     "auth_ref": [
      "r14"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag with value true on a form if it is an annual report containing audited financial statements.",
        "label": "Audited Annual Financial Statements"
       }
      }
     },
     "localname": "AuditedAnnualFinancialStatements",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://radnet.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_CityAreaCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Area code of city",
        "label": "City Area Code"
       }
      }
     },
     "localname": "CityAreaCode",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://radnet.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_CountryRegion": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Region code of country",
        "label": "Country Region"
       }
      }
     },
     "localname": "CountryRegion",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://radnet.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_CoverAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cover page.",
        "label": "Cover [Abstract]"
       }
      }
     },
     "localname": "CoverAbstract",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "xbrltype": "stringItemType"
    },
    "dei_CurrentFiscalYearEndDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "End date of current fiscal year in the format --MM-DD.",
        "label": "Current Fiscal Year End Date"
       }
      }
     },
     "localname": "CurrentFiscalYearEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://radnet.com/role/Cover"
     ],
     "xbrltype": "gMonthDayItemType"
    },
    "dei_DocumentAccountingStandard": {
     "auth_ref": [
      "r13"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The basis of accounting the registrant has used to prepare the financial statements included in this filing This can either be 'U.S. GAAP', 'International Financial Reporting Standards', or 'Other'.",
        "label": "Document Accounting Standard"
       }
      }
     },
     "localname": "DocumentAccountingStandard",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://radnet.com/role/Cover"
     ],
     "xbrltype": "accountingStandardItemType"
    },
    "dei_DocumentAnnualReport": {
     "auth_ref": [
      "r11",
      "r13",
      "r14"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as an annual report.",
        "label": "Document Annual Report"
       }
      }
     },
     "localname": "DocumentAnnualReport",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://radnet.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentFiscalPeriodFocus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fiscal period values are FY, Q1, Q2, and Q3.  1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.",
        "label": "Document Fiscal Period Focus"
       }
      }
     },
     "localname": "DocumentFiscalPeriodFocus",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://radnet.com/role/Cover"
     ],
     "xbrltype": "fiscalPeriodItemType"
    },
    "dei_DocumentFiscalYearFocus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.",
        "label": "Document Fiscal Year Focus"
       }
      }
     },
     "localname": "DocumentFiscalYearFocus",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://radnet.com/role/Cover"
     ],
     "xbrltype": "gYearItemType"
    },
    "dei_DocumentPeriodEndDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.",
        "label": "Document Period End Date"
       }
      }
     },
     "localname": "DocumentPeriodEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://radnet.com/role/Cover"
     ],
     "xbrltype": "dateItemType"
    },
    "dei_DocumentPeriodStartDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The start date of the period covered in the document, in YYYY-MM-DD format.",
        "label": "Document Period Start Date"
       }
      }
     },
     "localname": "DocumentPeriodStartDate",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://radnet.com/role/Cover"
     ],
     "xbrltype": "dateItemType"
    },
    "dei_DocumentQuarterlyReport": {
     "auth_ref": [
      "r12"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as an quarterly report.",
        "label": "Document Quarterly Report"
       }
      }
     },
     "localname": "DocumentQuarterlyReport",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://radnet.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentRegistrationStatement": {
     "auth_ref": [
      "r0"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as a registration statement.",
        "label": "Document Registration Statement"
       }
      }
     },
     "localname": "DocumentRegistrationStatement",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://radnet.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentShellCompanyEventDate": {
     "auth_ref": [
      "r13"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Date of event requiring a shell company report.",
        "label": "Document Shell Company Event Date"
       }
      }
     },
     "localname": "DocumentShellCompanyEventDate",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://radnet.com/role/Cover"
     ],
     "xbrltype": "dateItemType"
    },
    "dei_DocumentShellCompanyReport": {
     "auth_ref": [
      "r13"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true for a Shell Company Report pursuant to section 13 or 15(d) of the Exchange Act.",
        "label": "Document Shell Company Report"
       }
      }
     },
     "localname": "DocumentShellCompanyReport",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://radnet.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentTransitionReport": {
     "auth_ref": [
      "r15"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as a transition report.",
        "label": "Document Transition Report"
       }
      }
     },
     "localname": "DocumentTransitionReport",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://radnet.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentType": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.",
        "label": "Document Type"
       }
      }
     },
     "localname": "DocumentType",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://radnet.com/role/Cover"
     ],
     "xbrltype": "submissionTypeItemType"
    },
    "dei_DocumentsIncorporatedByReferenceTextBlock": {
     "auth_ref": [
      "r3"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Documents incorporated by reference.",
        "label": "Documents Incorporated by Reference [Text Block]"
       }
      }
     },
     "localname": "DocumentsIncorporatedByReferenceTextBlock",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://radnet.com/role/Cover"
     ],
     "xbrltype": "textBlockItemType"
    },
    "dei_EntityAddressAddressLine1": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name",
        "label": "Entity Address, Address Line One"
       }
      }
     },
     "localname": "EntityAddressAddressLine1",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://radnet.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressAddressLine2": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 2 such as Street or Suite number",
        "label": "Entity Address, Address Line Two"
       }
      }
     },
     "localname": "EntityAddressAddressLine2",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://radnet.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressAddressLine3": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 3 such as an Office Park",
        "label": "Entity Address, Address Line Three"
       }
      }
     },
     "localname": "EntityAddressAddressLine3",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://radnet.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressCityOrTown": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the City or Town",
        "label": "Entity Address, City or Town"
       }
      }
     },
     "localname": "EntityAddressCityOrTown",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://radnet.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressCountry": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "ISO 3166-1 alpha-2 country code.",
        "label": "Entity Address, Country"
       }
      }
     },
     "localname": "EntityAddressCountry",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://radnet.com/role/Cover"
     ],
     "xbrltype": "countryCodeItemType"
    },
    "dei_EntityAddressPostalZipCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Code for the postal or zip code",
        "label": "Entity Address, Postal Zip Code"
       }
      }
     },
     "localname": "EntityAddressPostalZipCode",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://radnet.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressStateOrProvince": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the state or province.",
        "label": "Entity Address, State or Province"
       }
      }
     },
     "localname": "EntityAddressStateOrProvince",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://radnet.com/role/Cover"
     ],
     "xbrltype": "stateOrProvinceItemType"
    },
    "dei_EntityBankruptcyProceedingsReportingCurrent": {
     "auth_ref": [
      "r6"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "For registrants involved in bankruptcy proceedings during the preceding five years, the value Yes indicates that the registrant has filed all documents and reports required to be filed by Section 12, 13 or 15(d) of the Securities Exchange Act of 1934 subsequent to the distribution of securities under a plan confirmed by a court; the value No indicates the registrant has not.  Registrants not involved in bankruptcy proceedings during the preceding five years should not report this element.",
        "label": "Entity Bankruptcy Proceedings, Reporting Current"
       }
      }
     },
     "localname": "EntityBankruptcyProceedingsReportingCurrent",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://radnet.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityCentralIndexKey": {
     "auth_ref": [
      "r2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.",
        "label": "Entity Central Index Key"
       }
      }
     },
     "localname": "EntityCentralIndexKey",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://radnet.com/role/Cover"
     ],
     "xbrltype": "centralIndexKeyItemType"
    },
    "dei_EntityCommonStockSharesOutstanding": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.",
        "label": "Entity Common Stock, Shares Outstanding"
       }
      }
     },
     "localname": "EntityCommonStockSharesOutstanding",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://radnet.com/role/Cover"
     ],
     "xbrltype": "sharesItemType"
    },
    "dei_EntityCurrentReportingStatus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.",
        "label": "Entity Current Reporting Status"
       }
      }
     },
     "localname": "EntityCurrentReportingStatus",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://radnet.com/role/Cover"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityEmergingGrowthCompany": {
     "auth_ref": [
      "r2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate if registrant meets the emerging growth company criteria.",
        "label": "Entity Emerging Growth Company"
       }
      }
     },
     "localname": "EntityEmergingGrowthCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://radnet.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityExTransitionPeriod": {
     "auth_ref": [
      "r19"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards.",
        "label": "Elected Not To Use the Extended Transition Period"
       }
      }
     },
     "localname": "EntityExTransitionPeriod",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://radnet.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityFileNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.",
        "label": "Entity File Number"
       }
      }
     },
     "localname": "EntityFileNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://radnet.com/role/Cover"
     ],
     "xbrltype": "fileNumberItemType"
    },
    "dei_EntityFilerCategory": {
     "auth_ref": [
      "r2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.",
        "label": "Entity Filer Category"
       }
      }
     },
     "localname": "EntityFilerCategory",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://radnet.com/role/Cover"
     ],
     "xbrltype": "filerCategoryItemType"
    },
    "dei_EntityIncorporationStateCountryCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Two-character EDGAR code representing the state or country of incorporation.",
        "label": "Entity Incorporation, State or Country Code"
       }
      }
     },
     "localname": "EntityIncorporationStateCountryCode",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://radnet.com/role/Cover"
     ],
     "xbrltype": "edgarStateCountryItemType"
    },
    "dei_EntityInteractiveDataCurrent": {
     "auth_ref": [
      "r16"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).",
        "label": "Entity Interactive Data Current"
       }
      }
     },
     "localname": "EntityInteractiveDataCurrent",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://radnet.com/role/Cover"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityPrimarySicNumber": {
     "auth_ref": [
      "r14"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Primary Standard Industrial Classification (SIC) Number for the Entity.",
        "label": "Entity Primary SIC Number"
       }
      }
     },
     "localname": "EntityPrimarySicNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://radnet.com/role/Cover"
     ],
     "xbrltype": "sicNumberItemType"
    },
    "dei_EntityPublicFloat": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant's most recently completed second fiscal quarter.",
        "label": "Entity Public Float"
       }
      }
     },
     "localname": "EntityPublicFloat",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://radnet.com/role/Cover"
     ],
     "xbrltype": "monetaryItemType"
    },
    "dei_EntityRegistrantName": {
     "auth_ref": [
      "r2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.",
        "label": "Entity Registrant Name"
       }
      }
     },
     "localname": "EntityRegistrantName",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://radnet.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityShellCompany": {
     "auth_ref": [
      "r2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.",
        "label": "Entity Shell Company"
       }
      }
     },
     "localname": "EntityShellCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://radnet.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntitySmallBusiness": {
     "auth_ref": [
      "r2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicates that the company is a Smaller Reporting Company (SRC).",
        "label": "Entity Small Business"
       }
      }
     },
     "localname": "EntitySmallBusiness",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://radnet.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityTaxIdentificationNumber": {
     "auth_ref": [
      "r2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.",
        "label": "Entity Tax Identification Number"
       }
      }
     },
     "localname": "EntityTaxIdentificationNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://radnet.com/role/Cover"
     ],
     "xbrltype": "employerIdItemType"
    },
    "dei_EntityVoluntaryFilers": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate 'Yes' or 'No' if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act.",
        "label": "Entity Voluntary Filers"
       }
      }
     },
     "localname": "EntityVoluntaryFilers",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://radnet.com/role/Cover"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityWellKnownSeasonedIssuer": {
     "auth_ref": [
      "r17"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A.",
        "label": "Entity Well-known Seasoned Issuer"
       }
      }
     },
     "localname": "EntityWellKnownSeasonedIssuer",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://radnet.com/role/Cover"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_Extension": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Extension number for local phone number.",
        "label": "Extension"
       }
      }
     },
     "localname": "Extension",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://radnet.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_LocalPhoneNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Local phone number for entity.",
        "label": "Local Phone Number"
       }
      }
     },
     "localname": "LocalPhoneNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://radnet.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_NoTradingSymbolFlag": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a security having no trading symbol.",
        "label": "No Trading Symbol Flag"
       }
      }
     },
     "localname": "NoTradingSymbolFlag",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://radnet.com/role/Cover"
     ],
     "xbrltype": "trueItemType"
    },
    "dei_OtherReportingStandardItemNumber": {
     "auth_ref": [
      "r13"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "\"Item 17\" or \"Item 18\" specified when the basis of accounting is neither US GAAP nor IFRS.",
        "label": "Other Reporting Standard Item Number"
       }
      }
     },
     "localname": "OtherReportingStandardItemNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://radnet.com/role/Cover"
     ],
     "xbrltype": "otherReportingStandardItemNumberItemType"
    },
    "dei_PreCommencementIssuerTenderOffer": {
     "auth_ref": [
      "r7"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.",
        "label": "Pre-commencement Issuer Tender Offer"
       }
      }
     },
     "localname": "PreCommencementIssuerTenderOffer",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://radnet.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_PreCommencementTenderOffer": {
     "auth_ref": [
      "r8"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.",
        "label": "Pre-commencement Tender Offer"
       }
      }
     },
     "localname": "PreCommencementTenderOffer",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://radnet.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_Security12bTitle": {
     "auth_ref": [
      "r1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Title of a 12(b) registered security.",
        "label": "Title of 12(b) Security"
       }
      }
     },
     "localname": "Security12bTitle",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://radnet.com/role/Cover"
     ],
     "xbrltype": "securityTitleItemType"
    },
    "dei_Security12gTitle": {
     "auth_ref": [
      "r5"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Title of a 12(g) registered security.",
        "label": "Title of 12(g) Security"
       }
      }
     },
     "localname": "Security12gTitle",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://radnet.com/role/Cover"
     ],
     "xbrltype": "securityTitleItemType"
    },
    "dei_SecurityExchangeName": {
     "auth_ref": [
      "r4"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the Exchange on which a security is registered.",
        "label": "Security Exchange Name"
       }
      }
     },
     "localname": "SecurityExchangeName",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://radnet.com/role/Cover"
     ],
     "xbrltype": "edgarExchangeCodeItemType"
    },
    "dei_SecurityReportingObligation": {
     "auth_ref": [
      "r9"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "15(d), indicating whether the security has a reporting obligation under that section of the Exchange Act.",
        "label": "Security Reporting Obligation"
       }
      }
     },
     "localname": "SecurityReportingObligation",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://radnet.com/role/Cover"
     ],
     "xbrltype": "securityReportingObligationItemType"
    },
    "dei_SolicitingMaterial": {
     "auth_ref": [
      "r10"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.",
        "label": "Soliciting Material"
       }
      }
     },
     "localname": "SolicitingMaterial",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://radnet.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_TradingSymbol": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Trading symbol of an instrument as listed on an exchange.",
        "label": "Trading Symbol"
       }
      }
     },
     "localname": "TradingSymbol",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://radnet.com/role/Cover"
     ],
     "xbrltype": "tradingSymbolItemType"
    },
    "dei_WrittenCommunications": {
     "auth_ref": [
      "r18"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.",
        "label": "Written Communications"
       }
      }
     },
     "localname": "WrittenCommunications",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://radnet.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    }
   },
   "unitCount": 3
  }
 },
 "std_ref": {
  "r0": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12"
  },
  "r1": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b"
  },
  "r10": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "14a",
   "Subsection": "12"
  },
  "r11": {
   "Name": "Form 10-K",
   "Number": "249",
   "Publisher": "SEC",
   "Section": "310"
  },
  "r12": {
   "Name": "Form 10-Q",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "308",
   "Subsection": "a"
  },
  "r13": {
   "Name": "Form 20-F",
   "Number": "249",
   "Publisher": "SEC",
   "Section": "220",
   "Subsection": "f"
  },
  "r14": {
   "Name": "Form 40-F",
   "Number": "249",
   "Publisher": "SEC",
   "Section": "240",
   "Subsection": "f"
  },
  "r15": {
   "Name": "Forms 10-K, 10-Q, 20-F",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "13",
   "Subsection": "a-1"
  },
  "r16": {
   "Name": "Regulation S-T",
   "Number": "232",
   "Publisher": "SEC",
   "Section": "405"
  },
  "r17": {
   "Name": "Securities Act",
   "Number": "230",
   "Publisher": "SEC",
   "Section": "405"
  },
  "r18": {
   "Name": "Securities Act",
   "Number": "230",
   "Publisher": "SEC",
   "Section": "425"
  },
  "r19": {
   "Name": "Securities Act",
   "Number": "7A",
   "Publisher": "SEC",
   "Section": "B",
   "Subsection": "2"
  },
  "r2": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r3": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b-23"
  },
  "r4": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "d1-1"
  },
  "r5": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "g"
  },
  "r6": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12, 13, 15d"
  },
  "r7": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "13e",
   "Subsection": "4c"
  },
  "r8": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "14d",
   "Subsection": "2b"
  },
  "r9": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "15",
   "Subsection": "d"
  }
 },
 "version": "2.1"
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>15
<FILENAME>0001683168-22-007504-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001683168-22-007504-xbrl.zip
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MQX]I4_#]6><4Y_9>>"@ 9J395H*4-,L@AA["=.2.A_3!6  E0)9[,RH!(4,
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M;B!"2%>IWD;?@;:U?/O<L[X=U*,YV\@>Z6YW].-W1W=;HKLMT1W '< =P!W
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M[;M5C;AUJ5((94[%IF3$A)TXB-K+!6L@J(0U7I9'(R&E7XHR&<OA*2[9D9\
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M<\:*P#EBLW6T]0X/X )4<U:[F0S;WR"\A._VC@%2E35E=/3D)SUP^H1F*<)
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MVMCIW?T=-4A/S30:"5.\U!%"+08^#/,OC!\^>?-LPMVR*FYQ[KHK#ML _H5
M1!(J5$4<0L1JH)NM0>WNB![,:N%/T Q.7?DA^KL0:$(4VIN@H419",#(S$\N
M;*(NR>-D3VI'F2FN_MV4&:^Z?V9P:@GS!$T;.M,'8$8C(8-/5Q-;39^&+CX
M?H_RZ)<6^/WS\KXAG#H?-&"T6/%'[]"J^SAQL ^\Z:"(3U;SC7J>.6()5\UI
M"KZ@2L-P0(<'!0+(&AGG0(\;Q]/3NT?9S/A"CEP^N7T</U$$I+U*@8D>+>@A
M']P_:QAROW%RU$?5<,N3H_L]6\H-H=&NXNZ+U%F\?.-6UW=T-+CY\=&=P<U5
M9^R;9E?<G/=DI/O&Z9W!+7NT/KWCL!TECNXV:+&^".>*O<#M[@X7?*^_^SB(
M<$Q/^25IZKO7:>HOD*:^>YVF_AWRTSM_$\&:F&L;B$BU%Y+QP!H*B0VHUI9
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M;@O8():1_E/II+6W"MW:FSL33LWD).4AS'+'1>+1.K.YGLUVX&?Q^K<;$XJ
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M4;[QQ?[.IOTK;!H;"PEK%%\G]"%JJ0;TQ@"0;?\5Y]I@EL])?P&!:R^CW,/
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M1BHXE9W V[EW'^HFMJ]9'P?2>SX AZ*'"LW 6FH0(EH&P( 6IV2,:.,IB-C
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M+A[(S!Z/ZX%,@D-Z34%H.%#RS1=81PG*59)87'KSYY8)V@N%HE(.?D:$%X"
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M  "YD0  #0              @ $     <F%D;F5T7SAK+FAT;5!+ 0(4 Q0
M   ( *5N:E5P]BW(#40  !AL 0 1              "  3@4  !R861N971?
M97@Y.3 Q+FAT;5!+ 0(4 Q0    ( *5N:E4NHDX@30,  +,,   1
M      "  718  !R9&YT+3(P,C(Q,3 Y+GAS9%!+ 0(4 Q0    ( *5N:E66
M4YSP_@H  ("&   5              "  ?!;  !R9&YT+3(P,C(Q,3 Y7VQA
M8BYX;6Q02P$"% ,4    " "E;FI5S&SP>U0'  #15P  %0
M@ $A9P  <F1N="TR,#(R,3$P.5]P<F4N>&UL4$L%!@     %  4 /P$  *AN
$      $!

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
